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ABSTRACT 
The growing number of drug resistant strains of Mycobacterium tuberculosis 
appearing worldwide has had an enormous impact on the ability to control and treat 
Tuberculosis (TB). Discovering new anti-TB drugs is of paramount importance to the 
global effort for TB eradication. The success of the pathogen is largely due to its 
inherent ability to remain in a non-replicating or latent state for extended periods of 
time. In order to achieve this shift it requires tightly controlled signal transduction 
mechanisms to respond to its host environment. Two component systems (TCS) are 
one example of signalling mechanisms employed by prokaryotes and are ideal 
candidates for antibacterial drug targets. It is understood that many TCS are 
conserved in a large number of organisms, they are often essential to the virulence 
and persistence of pathogens and they are virtually exclusive to prokaryotes. In this 
study three Mycobacterium smegmatis TCS were selected; DevS/DevR, MtrB/MtrA 
and SenX3/RegX3. Promoters under the control of these systems were cloned into 
an optimised mycobacterial high copy number GFP reporter plasmid and subject to a 
number of in vitro stress conditions to ascertain induction conditions for these 
systems. As expected the DevS/DevR controlled hspX promoter was responsive to 
oxygen starvation and the SenX3/RegX3 controlled phoA was induced by phosphate 
starvation. Interestingly, phoA and mtrA were also induced by magnesium chelator 
EDTA in minimal media.  
The phoA and mtrA promoter constructs were then used for in vitro high throughput 
bioassays with a number of compound libraries in order to screen for any inhibitory 
activity on each of the target systems. A phosphorylation inhibitor included in one of 
the screens, oleic acid, indicated that this assay could potentially be used to screen 
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for TCS inhibitors, but no novel compounds were found in this study. As a proof of 
principle, known TCS inhibitors palmitoleic and oleic acid were employed to show a 
dose dependent inhibition mtrA expression. This method could potentially be 
expanded to other TCS of Mycobacterium smegmatis and Mycobacterium bovis 
BCG, or other signal transduction systems such as one component regulators and 
serine threonine kinases. 
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1.1 Background 
Mycobacterium tuberculosis has been a significant human pathogen for thousands of 
years 1, 2. Without a natural reservoir of its own, some consider it to have co-evolved 
with humans 2-4. Studies have shown evidence of M. tuberculosis infection in 
Egyptian and Incan mummified remains  up to 9,000 years ago 2-4 and the 
domestication of cattle around 10,000 years ago 5, 6 was thought to be implicated in 
the origins of this disease 7. Modern molecular methods have since indicated that the 
causative agent of bovine tuberculosis, Mycobacterium bovis, is a more recent 
species, having evolved from human specific M. tuberculosis ancestry 3, 8. Ancient M. 
tuberculosis DNA, containing none of the four splogiotypic groups used to distinguish 
the species from M. bovis, has been found in humans and animals dating back long 
before cattle domestication 9. A recent paper suggests that modern M. tuberculosis 
may have evolved from a similar prehistoric pathogen found in Homo erectus up to 
500,000 years ago 10. While M. tuberculosis is clearly an ancient species, direct 
evidence of outbreaks of phthisis, consumption and the white plague cannot be 
traced back as far as the organism itself 3.    
Whether pathogenically inert or otherwise, M. tuberculosis has infected mankind for 
a substantial proportion of our existence. Robert Koch, who first isolated the acid fast 
bacillus (AFB) in 1881, estimated at the time that one in seven humans died of 
Tuberculosis (TB) 11.  Later in 1898, Smith identified different types of mycobacteria 
that infect livestock, who shared the hardy mycolic acid cell wall 12. Since then, our 
knowledge of the Mycobacterium genus has expanded to 71 species, 32 of which 
are pathogenic, these have been classified in a Runyan scheme by various features 
including pigmentation and rate of growth 12.  More recently, the evolutionary 
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distance between species has been further defined by the analysis of mycolic acid 
structures, genetic markers such as the 16S rRNA gene and, in the last decade, the 
comparison of entire genomes 8-10. Members of the Mycobacterium tuberculosis 
complex are generally responsible for disease in humans and cattle; however a 
number of opportunistic Mycobacteria can give rise to infection in an immuno-
compromised host. Slow growers such as Mycobacterium celatum and 
Mycobacterium abscessus can infect patients with Acquired Immune Deficiency 
Syndrome (AIDS) or chronic immune suppression, while post-traumatic infection is 
generally caused by fast growers such as Mycobacterium goodie  12. Comparing 
pathogenic and non-pathogenic species has been a useful tool in understanding the 
evolution of the Mycobacterium tuberculosis complex and its host-specific virulence 
13. 
Mycobacterium smegmatis, a non pathogenic soil bacterium, has been extensively 
used as a model organism owing to its rapid doubling time of three hours compared 
with M. tuberculosis’ 12hours 12, 14. Another model organism is the vaccine strain M. 
bovis BCG (Bacille Calmette-Guérin) whose sequence is 99.95% identical to that of 
M. tuberculosis 15. These and other models will be discussed in section 1.2.3. 
1.1.1 The Development of TB Treatment 
TB has been a human disease for thousands of years and a range of treatments and 
therapies have been explored. Many significant events have lead to the current 
understanding and treatment of TB and other infectious diseases today. The Royal 
College of Physicians was set up in 1518 by Henry VIII to fight the bubonic plague 
and meant that physicians of the time could monitor infectious outbreaks in order to 
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circumvent the devastating effects disease was having on a rapidly growing 
population 16. The burden of TB was probably intensified by overcrowding and 
urbanisation, becoming a major cause of death by the Industrial Revolution 17.  TB 
was no exception to the emerging idea that living conditions play as significant a role 
as the disease itself, something which is still a very important factor in TB control 16. 
Records show deaths attributed to TB in England and Wales fell from 62,633 to 
27,871 between 1878 and 1940, testament to the effect of an improved standard of 
living on the disease 16.  
Another common feature of infectious endemic is war 18. Devastating outbreaks of 
infectious diseases in post war Europe fast tracked the antibiotic era with the 
discovery of penicillin in 1928 by Fleming and then streptomycin (SM) in 1944 by 
Waksman, Schatz and Bugie 16-18. Prior to this point, the most common form of 
treatment for TB had been fresh air and bed rest 19 so Waksman’s discovery in 1943 
of a broad spectrum antibiotic that eliminated M. tuberculosis infection in most 
patients revolutionised its treatment and lead to a sharp decrease in mortality. 
 Preventative therapy by immunisation with a live attenuated strain of M. bovis BCG 
was pioneered in 1921 and first given to “at risk” groups such as nurses and medical 
students in 1949 16. In one of the first large-scale medical research trials in the 
United Kingdom, 52, 239 children were immunised between 1950 and 1952 with the 
attenuated strain of M. bovis BCG 16. The incidence of TB decreased 79% between 
1954 and 1965 which was probably a combination of drug and vaccine efficacy as 
well as an improved standard of living, which reduced the infection rate 16.  
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Thousands were saved by vaccination and antibiotic development, but it did not take 
long for SM resistant strains of M. tuberculosis to emerge 20. The discovery of 
pyrazinamide (PZA), isoniazid (INH) and rifampin (RIF) meant that TB could be 
relatively well controlled and combined therapy could be administered to avoid the 
emergence of resistant strains 21, 22. Eventually a growing number of patients 
presented strains resistant to each of the available anti-tubercular agents prompting 
scientists in the field to search for new classes of antibiotics.  
Presently, drug resistant strains are classified as either multi drug resistant (MDR) or 
extensively drug resistant (XDR) based on the number and class of antibiotics to 
which susceptibility has been lost. MDR strains of M. tuberculosis are defined by the 
World Health Organisation (WHO) as having “resistance to at least INH and 
rifamycin” and XDR is described as “resistance to at least INH and RIF among first-
line anti-TB drugs, resistance to any fluoroquinolone, and resistance to at least one 
second-line injectable aminoglycoside (amikacin, capreomycin, or kanamycin)”  23. 
M. tuberculosis’ ability to acquire genotypic and phenotypic resistance to these drugs 
is of great importance to physicians administering these drugs and to drug discovery 
efforts 23. 
1.1.2 Drugs and resistance 
The treatment of TB has evolved from concoctions of distilled milk infused with earth 
worms and snails to modern synthetic  pro drugs like INH 20, 24. It is impossible to say 
how effectively some of the early remedies such as cod liver oil, arsenic and iodine 
worked to reduce the TB burden at the time, but some interesting discoveries began 
to emerge at the turn of the 20th century. In 1912 studies employed the use of 
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cultured Bacillus subtilis and Bacillus mesentericus to inhibit the growth of M. 
tuberculosis in vitro and in a guinea pig model 20. Later, the use of sulfonamides 
showed great anti-mycobacterial potential in vitro, but were far too toxic for use in the 
treatment of pulmonary TB 20.  
Streptomycin (SM) was isolated from Streptomyces griseus in 1943 and before the 
end of 1944 it was being used in clinical trials against TB, showing efficacy in vivo 
and in vitro 20, 25. SM was quickly moved to industrial scale production as it showed 
an effect on a broad spectrum of organisms including Gram negative, Gram positive 
and acid fast bacteria 25. SM is an aminoglycoside antibiotic which acts on bacterial 
ribosomes inhibiting translation initiation and causing misreading 26. Various strains 
have been sequenced to identify polymorphisms responsible for drug resistance in 
mycobacteria recorded by the drug resistance mutation database 
(http://www.tbdreamdb.com) 27.  Genes encoding the ribosomal subunits rrs and rpsL 
have been implicated in resistance to SM and other aminoglycoside  22, 26. 
Current first line drugs include INH, rifampin, ethambutol (ETB) and pyrazinamide. 
INH acts on mycolic acid synthesis, inhibiting cell wall synthesis 28. It is a 
nicotinamide-derived drug first discovered in the 1950s, and proved more effective 
than any anti TB drug of its time 24. Resistant isolates were discovered the same 
year as the drug. However, it was nearly half a century before genetic analysis of 
these isolates lead to the elucidation its mode of action  24. INH is a pro drug 
activated by the M. tuberculosis KatG protein and certain polymorphisms in this gene 
give rise to INH resistance 24. PZA is an interesting drug, owing to its inactivity in 
vitro 29. The mode of action of PZA is currently unknown, but its effect in an 
anaerobic environment is far more pronounced than in aerobic conditions 29. Its 
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activity on so called “semi dormant” bacilli has reduced the treatment time of TB from 
12 to 6 months 29. A number of mutations to pncA gene and promoter region result in 
reduced susceptibility to this drug 27. 
The evolution of drug resistant strains of mycobacteria is influenced by many factors. 
On a clinical level, the existence of many sub populations within a host, sometimes 
in more than one location therein, as well as an inherent ability to survive in either an 
active or dormant state engenders resistance 22. Host specific factors also contribute 
to the likelihood of drug resistance developing such as the strength of innate 
immunity, HIV status and whether or not a patient has been treated for TB previously 
13. Studies have shown that the likelihood of MDR or XDR-TB arising is much higher 
if the patient has been previously treated for TB or is HIV positive 23, 30. The latest 
WHO figures show that countries where the incidence of MDR and XDR-TB is 
highest include countries such as South Africa, Ukraine and Latvia where the 
number of people with HIV and AIDS is also high 23, 31. Previous treatment is another 
important factor, as low quality drugs, incorrect prescription and poor adherence will 
affect the probability of resistance arising 27, 32.  
On a molecular level, mutations causing polymorphisms within a population can lead 
to a subpopulation of resistant bacteria 33. Mutation can arise spontaneously or as a 
result of exogenous agents causing DNA replication errors. Point mutations, 
insertions, duplications or loss of genetic material can result in a change of 
phenotype allowing an organism to become resistant to a drug which usually knocks 
out an essential process 34. In some ways the more critical the target to cellular 
replication, the more likely resistance will arise. The rate of mutation in pathogenic 
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mycobacteria is relatively low compared with faster growing pathogens, however 
there are many genes which display variable mutation rates 35. 
There are many reasons M. tuberculosis is able to develop resistance to drugs 
including its extended incubation and latency period as well as the fact that most 
drugs act on targets essential for growth and division 13, 22. As well as these 
documented genotypic changes, the idea of reversible phenotypic drug resistance is 
a concept that may well be central to M. tuberculosis drug susceptibility. The idea 
that sub populations of bacteria can survive exposure to drugs by a phenotypic 
switch to a reductive metabolism, rather than a permanent genotypic change is a 
relevant argument for the case of mycobacteria 36. 
1.1.3 Epidemiology 
The WHO annual surveillance report on TB for 2009 gives a summary of the current 
state of TB as well as strategies to combat the disease worldwide 23. Encouragingly 
the report indicates that the number of new TB cases per capita has decreased since 
2003, however with 9.27 million new cases and 1.3 million deaths in 2007, these 
alarming statistics show there is still a long way to go before TB is completely 
eradicated 23. The highest incidence per capita is in Africa with an average rate of 
363 per 100,000 and 14.4 deaths in 2007 23. The USA and Monaco have the world’s 
lowest prevalence rates of 3.1 and 1.9 per 100 000 respectively, while Swaziland 
has the highest rate with 1,226 per 100 000 23.  
The WHO gives the latest prevalence of TB in New Zealand as 7.3 per 100,000 for 
2007 and ESR (Institute of Environmental Science and Research) recorded this rate 
as 7.2 per 100,000 in 2008 23, 30. Five new cases of TB were recorded in its latest 
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public health survey report for July and September 2008 all of which were in 
Wellington 30. TB has a very strong association with poverty and age in NZ 37. Unlike 
countries with a high prevalence of HIV, the majority of TB cases are found in older 
people, children and people in a low income bracket 37. Although globally the rate of 
TB has dramatically decreased in the last hundred years, thanks to the availability of 
antibiotics and a higher standard of living in most countries, the emergence of MDR 
and XDR strains of TB is of huge concern 23. First line TB drugs can be used in most 
cases to treat TB. Second line drugs are used in cases of drug resistance; however 
they are more expensive, must be administered for longer and display severe side 
effects 23, 37.   
Drug resistant TB is not geographically isolated, according to the WHO 2008 report 
MDR TB was detected all over the world and at least one case of XDR TB was 
reported in all 45 countries surveyed 23. Globally, it is estimated that 3.9 to 6.6 % of 
all cases of TB are MDR 23. The highest rates of MDR-TB in the world are recorded 
in Eastern Europe especially in Latvia and Ukraine (up to 36 % of all cases), much 
higher than in Africa 23. Data from these countries has shown that the percentage of 
MDR-TB is significantly different in new cases at 2.9 % compared with previously 
treated cases at 15.3 % 23. Some associate this with a sharp increase in the number 
of HIV cases reported in this area 23, it may also be that Eastern Europeans 
countries have a very effective surveillance strategy for MDR and XDR-TB and are 
picking up more cases than other countries.  
The STOP TB strategy set up in 2006 includes an expansion of the directly observed 
therapy (DOTS) regime to 184 countries and addresses the challenge of TB HIV co 
infection 32.  
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In addition to an increased susceptibility to TB, a positive HIV status is significant 
because it will affect drug resistance and the host immune response to TB, 
precipitating the onset of disease 23. Testing for HIV status among TB cases in high 
risk areas has increased from 8% to 35% since 2002 23. A very important part of TB 
research is recording information from around the world showing trends of drug 
resistance. Drug susceptibility testing (DST) is one way that MDR and XDR can be 
monitored and managed 32. Although mutations causing resistance to current TB 
drugs are unavoidable, ensuring that the right combinations of drugs are given to 
patients is one way that the rate of MDR and XDR-TB can be reduced.   
Currently, the discovery of new anti-TB drugs is of paramount importance in the 
effort to stop TB. In order to combat emerging drug resistant strains new targets 
need to be elucidated. Our focus is on latent TB and the following section will 
describe the progression, persistence and virulence of TB and why targeting latent, 
in addition to active, TB could help to alleviate this global epidemic.  
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1.2  Immunology and persistence 
One of the most challenging features of TB treatment is the organism’s ability to 
maintain a dormant state within its host for long periods of time 34, 38. This section will 
outline the progression of TB with an emphasis on factors which affect the disease 
outcome for patients and morphological and genetic changes within M. tuberculosis 
which allow it to persist for so long. 
1.2.1 Disease progression 
M. tuberculosis is an obligate pathogen, unlike some other mycobacterial species it 
has no environmental niche but can live in humans asymptomatically for long periods 
of time 39. Given that one in three humans harbours latent TB, there is in fact a huge 
reservoir of M. tuberculosis worldwide 
(http://www.who.int/mediacentre/factsheets/fs104/en/). Infection begins with 
inhalation of aerosols containing M. tuberculosis AFB to pulmonary alveoli 36, 37. The 
presence of foreign pathogenic bacteria is very quickly recognised by the host 
immune cells via bacterial toll like receptors (TLR) and mannose receptors 36, 38. 
Macrophages and dendrites are recruited to the site of infection where they 
phagocytose bacterial cells. In non-pathogenic mycobacteria this results in efficient 
control of the infection since macrophages induce the elimination of bacilli by 
phagolysosome fusion, complement activation and lymphocyte mediated killing 40. 
During M. tuberculosis infection, most of the AFB are cleared in this manner but in 
approximately one third of cases, the pathogen persists by interfering with 
macrophage maturation 38, 41 as shown in figure 1.1.  
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Figure 1.1: Disease Progression in TB. In most cases AFB are cleared by the immune 
system. Active TB results from expansion of the primary granuloma (A) or re-activation (B) of 
contained AFB 
Various mechanisms of immune evasion have been proposed which are described in 
a number of reviews 36, 38-41. Although the infected macrophage cannot induce the 
release of toxic lysosomal products to the AFB containing phagosome, there is still a 
large immune response from the host 40. This leads to a gathering of immune cells 
forming a tubercular lesion known as a granuloma. These characteristic lesions are a 
hallmark in TB diagnosis and range in size and cellular makeup depending on stage 
of disease 42. In about 90 % of individuals, the AFB are contained in the granuloma 
which consists of dead and foamy macrophages surrounded by activated 
macrophages and lymphocytes 41, 43. There is often a surrounding fibrotic layer 
leaving the AFB in a contained environment 43, 44. In a small number of individuals 
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the initial infection will lead to primary tuberculosis after an incubation period ranging 
from 4 to 12 weeks 43. Dissemination of the primary granuloma results in active TB 
by allowing AFB to spread to other regions of lung and eventually other organs of the 
host 36, 37.  
1.2.2 The Tubercular Granuloma 
The host adaptive immune response results in the formation of a granuloma; 
providing protection from but not sterilization of an M. tuberculosis infection 40. This is 
also seen in other pathogens such as those of the Schistosoma and Brucella genera 
44.The large number of immune cells recruited to the site of infection is exaggerated 
during a TB infection, effectively encapsulating the AFB to the initial infection foci. 
After AFB enter a macrophage they are transported across the epithelial lining where 
they recruit more immune cells to the site. This recruitment requires the Region of 
Difference (RD1) virulence gene locus 45. Ulrichs and others showed that the type of 
cell arriving at the granuloma changes with time, after 4 weeks 45 % of the cells are 
macrophages whereas at 6 weeks 80 % are lymphatic cells 42. 
A number of reviews describe the structure of the granuloma and the general 
consensus is that there is a necrotic core surrounded by concentric rings of immune 
cells 36, 41, 42. AFB reside in macrophages surrounded by a mass of cellular material 
consisting of dead macrophages and Langhans giant cells, the latter having formed 
by the fusion of epitheloid macrophages 42. This layer is surrounded by a number of 
activated macrophages, surrounded by naive macrophages and T lymphocytes. A 
number of others components are involved in this organised structure including B 
lymphocytes, dendritic cells, neutrophils, fibroblasts and extracellular matrix 44. 
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Surrounding tissue keeps the entire structure in check by secreting chemokines and 
cytokines 42. The aggregation of T cells around the fibrotic layer acts as mini lymph 
nodes surrounding the healing granuloma 42, 43. The conditions within the tubercular 
granuloma have been studied extensively using a number of models; certain areas 
of the granuloma have been shown to be hypoxic, nutrient and iron deprived, and 
contain toxic nitric oxide products 42, 44.  
The cellular composition of the granuloma is altered depending on whether the 
lesion is healing or disseminated and the centre of the granuloma can either be 
casious or calcified 42. Other differences in these states are the presence of blood 
supply in an active granuloma and fibrotic coating surrounding the healing 
granuloma keeping AFB contained to the site of infection 42. One of the most 
important factors affecting the rate of healing is the bacillary load present in the lungs 
45. Other host factors will also determine how quickly the granuloma heals, in 
particular the health of the individual’s immune system.  
There is debate as to whether the granuloma is in a constant or dynamic state 42, 45. 
The historical view of granuloma formation implies that after infection granulomas 
heal over time unless certain host factors trigger re-activation 42. This static view 
implies that the dormant bacilli are contained in the granuloma, employing a 
reductive metabolism in order to survive in the hypoxic nutrient deprived lesion for 
extended periods of time until resuscitated. Numerous studies in different models 
have shown that TB is able to switch to a dormant state during LTBI 45-48. There is, 
however, mounting evidence that this may not be the case for every single AFB. For 
example, the finding of  M. tuberculosis DNA outside the granulomatous lesions of 
patients with LTBI indicates that AFB could be escaping from granulomas even 
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during an LTBI 49. The problem here is that the presence of DNA does not 
necessarily prove that live M. tuberculosis survives in the lung. To date the presence 
of RNA, indicative of live M. tuberculosis, has only been found within macrophages 
in non-necrotic zones of the granuloma 44. 
 The dynamic hypothesis describes a state seen in the M. marinum model where the 
AFB  are contained by fibrotic tissue surrounding the granuloma but can escape to 
other areas of the lung with the help of macrophages 45. In this view, infection 
remains controlled even though the lesions are moving around the lung; more 
forming as older ones heal completely 45. Unfortunately, which view you take is 
largely dependent on what model organism and host you are studying. As there is 
really no perfect model for LTBI in humans, all of the evidence obtained using 
different model organisms and hosts needs to be carefully considered.  In any case, 
there is something unique about the ability of M. tuberculosis to maintain a slow 
growing persistent state in response to the harsh environmental conditions it faces. 
The granuloma effectively houses the infectious agent for extended periods of time. 
This can lead to endogenous re-activation of the disease in a compromised host. 
There is much debate as to whether the majority of current TB cases are the result of 
exogenous re-infection of AFB or endogenous re-activation from a previous infection 
41. Given that so many humans harbour latent TB, yet only a small proportion of 
those exposed to the pathogen develop a latent or active infection, one could argue 
that both processes are very important in post primary TB.  
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1.2.3 Endogenous Re-activation and Exogenous Re-infection 
A number of studies attest to M. tuberculosis’ ability to survive for long periods of 
time in a dormant state in vivo and in vitro 16, 45-48. There is evidence that TB can 
survive in a human host for up to 33 years 48. Re-activation occurs when a 
granuloma disseminates and infected macrophages spread to other parts of the lung 
42, 50. The ratio of cases which arise from re-activation and re-infection is unknown 
but it is likely that a number of host factors are involved in the outcome. A Latent TB 
infection (LTBI) is maintained by a delicate balance between the host immune 
system and the population of AFB in the granuloma 42. Immune suppressant drugs 
such as infliximab have been shown to greatly increase the rate of re-activation 51. 
Malnutrition, old age and co-infection with HIV have all been shown to increase re-
activation rates 13, 34. Even genetic differences within individuals of a population can 
influence the odds of re-activation, for example polymorphisms on chromosome 
regions 2q21-2q24 and 5p13-5q22 have been linked to susceptibility to re-activation 
52.  
On the other hand many of these factors could also increase the likelihood that an 
individual is susceptible to re-infection. Consider that a malnourished, elderly or HIV 
positive patient is probably much more likely to be unable to control a new infection if 
they live in an area with a high risk of contagion. As we learn more about the 
granuloma status in latent and active TB it seems likely that both re-activation and 
re-infection contribute to the current epidemiology of the disease. There may be an 
entire spectrum of disease states in these lesions. The AFB may be replicating very 
slowly and causing new lesions which heal without ever causing active disease until 
there is a break down in the immune system control causing re-activation or an 
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increase in AFB number as a result of re-infection 45. In either case, the fact that TB 
can survive in this latent phase, providing such a large reservoir of AFB developing 
drug tolerance and resistance, make it an extremely dangerous pathogen.       
1.2.4 Models of Persistence 
Before discussing the ability of M. tuberculosis to enter dormancy, it is necessary to 
explain some of the models used to explore the dynamics of mycobacterial gene 
expression and host responses to the AFB during LTBI. H37Rv, a common lab strain 
of M. tuberculosis, is restricted to physical containment level 3 facilities in New 
Zealand. This precaution and its long doubling time of 12 hours make it a difficult 
organism to work with, thus other species of the mycobacterium genus have been 
used in its place. M. smegmatis and M. bovis BCG are commonly used to explore 
changes involved in dormancy 48, 53. Other related mycobacterial model organisms 
include zoonotic pathogens  M. avium and M. marinum 12.  
The Wayne model is an in vitro model used to explore changes in gene expression 
during stationary phase 54. It involves a slow starvation of oxygen to a point where 
the optical density (OD) of the cell culture is constant but the cells remain viable 55. 
This model was originally established in the 1970s and the authors discovered that 
genes involved in the glycoxylate shunt were up-regulated during this growth phase 
56. Three markers of dormancy were described namely, tolerance to anaerobiosis, 
unique antigen production and a significant increase in the production of glycine 
dehydrogenase and isocitrate lyase enzymes 56. These changes mean that M. 
tuberculosis can use up less energy and persist in a slow or non-replicating state. 
Many of these findings have been replicated by two dimensional gel and microarray 
TH1 
 
TH1 
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analysis showing upregulation of icl and aceA genes during stationary phase and 
during in vivo infection 57. Other variations on this model achieve stationary phase 
persistence by altering temperature, pH, nutrient sources and nitric oxide levels 44. 
While in vitro models cannot replicate the hostile environment of the granuloma, 
many mycobacterial species exhibit similar changes as a result of oxygen starvation 
to those seen in vivo such as antibiotic tolerance, down regulation of a number of 
genes involved in active metabolism and induction of a set of genes known as the 
dormancy regulon 47. In vivo induced genes have also been categorised by infection 
with human macrophage cells 44.  Some of these can be further broken down to 
groups of macrophage and granuloma activated genes 44. The different subsets 
show that there are some intrinsic host factors required to fully appreciate dormancy 
in human LTBI 44. 
The Cornell model has been used extensively to discover more about in vivo 
adaptation by M. tuberculosis. This model involves drug induced immunosupression 
in mice 36, 65, 66.  After infection, a mouse will generally clear most of the AFB without 
causing disease until treatment with steroids causes M. tuberculosis re-activation. 
While much of what we know about in vivo gene expression and host response is 
derived from this model, it does have its limitations. The bacterial load required for a 
TB infection in mice is much higher than what is usually seen in humans 44. 
Consequently, the mice end up with a chronic infection causing severe damage of 
the lung, rather than the anaerobic calcified granuloma seen in humans 36, 43.  
Another problem is that the administration of drugs is not standardised across the 
field which may cause discrepancies in results 44.  
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These problems have lead to the exploration of other host organisms. Guinea pigs 
are much more susceptible to M. tuberculosis infection and produce granulomas of 
similar pathology to those in humans 36, 67. Rabbits also show a similar pathology 
with caseous and calcified healing lesions however, they are resistant to M. 
tuberculosis  infection and will only be infected by M.bovis 44.  
Using other species of mycobacteria in their specific host is another way of 
determining how persistence can be achieved. Although they will not fully represent 
the human disease, many of the mechanisms used to survive intracellular conditions 
are similar. Members of the M. avium subspecies are obligate pathogens which 
infect chickens and cause Crohn’s disease in immune compromised humans 12. M. 
bovis is 99.95 % similar to M. tuberculosis on a nucleotide level and infects a number 
of animals including goats, pigs and sheep 15. Interestingly M. bovis, which is more 
recently evolved than M. tuberculosis from the original progenitor of the complex, the 
loss of certain genetic elements exhibits a broader host range 15.  
Avirulent M. bovis BCG has been used as a vaccine strain for many years and a 
particular region that was lost in BCG is the previously mentioned RD1 region 36, 68. 
This genetic region was recently studied in M. marinum, which can cause disease in 
frogs and fish 45. It is a particularly useful model as it infects macrophages and gives 
a similar granuloma structure to the closely related M. tuberculosis. The 
aforementioned work used this species in zebrafish embryos to determine formation 
and stability of granulomas in this species.  
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1.2.5 The Dormancy response 
Using the models described, significant advances have been made in elucidating the 
dormancy response during persistence in a granuloma. Transposon mutagenesis 
studies have implicated a number of genes for survival of M. tuberculosis at various 
stages of infection 46. The pathogen must respond rapidly to environmental cues in 
order to alter its proteome and adapt to these harsh conditions using tightly regulated 
signal transduction mechanisms. Some of the important cellular changes will be 
described.   
The RD1 Region 
The development of the M. bovis BCG vaccine strain involved serial passage of the 
strain until it reached an avirulent state 58. Genotyping the vaccine strain revealed 
the loss of two significant genetic regions, esat6 and cfp10 collectively known as the 
RD1 region. A BCG:RD1 knock in strain displayed an increase in virulence that was 
not entirely restored with respect to the wild type strain 58. RD1 mutants have a 
different morphology to wild type and do not form a granuloma structure. A recent 
study confirmed that this genetic region was vital in maintaining persistence in a 
granuloma using the M. marinum zebrafish model 45.  
The distinct layers of a granuloma suggest that these lesions are not a random mass 
of cellular material but an organised structure which forms as macrophages are 
activated by AFB, leading to aggregation of mononuclear phagocytes 59. Davis et al. 
found that the M. marinum RD1 mutant was attenuated in its ability to form a 
granuloma. The main distinctions they found in macrophage aggregation from the 
RD1 mutant compared with wild type included differences in the speed and 
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morphology of macrophages recruited to the infection foci. The granuloma expansion 
was also different; in wild type cells a continual expansion of the granuloma was 
observed through cycles of apoptosis and phagocytosis, while the mutant showed no 
chemotaxic recruitment of macrophages. 
Other changes involved in the dormancy response include the induction of the so 
called dormancy regulon. Over 40 genes are induced by the DevS/ DevR two 
component system (TCS) in response to conditions of low oxygen and nitric oxide 60-
62. These include enzymes required for glycoxylate metabolism, shown in the 
previously mentioned Wayne model 56, a number of other stress response genes are 
induced by this TCS, including the hspX gene 62-64.   
Changes to the cell wall structure of the pathogen involving the PhoP/ PhoR system 
are also noted during latency 57, 70-73. A review on the potential of cell wall 
components as drug targets describes multiple changes in the cell wall composition 
as a result of stationary phase in mycobacteria 65. The author describes possible 
changes to the amount and conformation of mycolic acid, a change in the ratio of 
cross-linked peptidoglycan and a decrease in the level of arabinogalactan present 
during dormancy 65.    
All of the mechanisms which M. tuberculosis uses to evade immune responses and 
survive latently in an intracellular environment rely on adapting to life in the 
macrophage. The AFB is able to do this via a number of signal transduction 
mechanisms which tightly control gene expression in response to extra and intra 
cellular changes it encounters.  The current understanding of changes to the mycolic 
acid structure of the AFB cell wall during infection raises questions about the efficacy 
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of cell wall related drug targets, such as INH, for treating latent TB 65. The AFB’s 
switch to a more reductive metabolism will also render drugs which target active 
replication poor candidates against latent infection. In order to eliminate the sizable 
reservoir of latent TB worldwide, new candidates that act on targets utilised during 
this dormancy phase are required.  
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1.3 Cellular Signalling 
Every living organism must have tightly controlled sensing mechanisms in order to 
survive in and respond to its particular niche. Both prokaryotic and eukaryotic cells 
employ a number of responsive systems and processes, without which they would 
be rendered defenceless in the face of any changes in their respective 
environments. Organisms adapt to life in specific conditions with relation to 
temperature, pH, and the availability of nutrients and oxygen, to name a few. How 
well an organism adapts to a changing environment determines its survival and 
evolutionary fitness.    
In M. tuberculosis, signalling molecules and systems allow the organism to live in the 
hostile environment of the human immune system induced granuloma for extended 
periods of time, making these structures attractive drug targets. Their relative 
distance, in terms of homology, from eukaryotic signalling systems means that 
inhibitors of prokaryote signal transduction are less likely to evoke a negative 
response in the human host. This section will highlight important prokaryote 
signalling mechanisms seen in mycobacteria, with an emphasis on the two 
component systems (TCS) which are the focus of this study. 
1.3.1 Classes of Prokaryote Signalling Molecules found in mycobacteria 
In response to external signals, prokaryotes employ single and multi protein 
phosphorelay systems to interpret and respond to external ligands. This results in 
control of gene expression by either transcriptional control or post translational 
modification of proteins. Histidine kinases (HKs) are generally part of two component 
system signal transduction. Other sorts of protein kinases include serine threonine 
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and tyrosine kinases. The earliest evidence for reversible phosphorylation in 
prokaryotes was unearthed in the 1970s 66. This sort of mechanism had only been 
revealed in eukaryotes and the bacteriophage T7, so the discovery of serine 
threonine kinases in Salmonella typhimurium 66 preceded a surge of interest in this 
area. 
One Component Regulators  
One component signalling, as the name implies, requires just one protein with 
sensor and effector domains 67. Intracellular changes are recognised by the sensing 
domain which results in DNA binding of the effector, which acts as a transcriptional 
activator or repressor 67. Some well known examples include the TetR and AraC 
proteins in E.coli, which respond to L-arabinonse and tetracycline respectively 67. 
The simplest AraC type regulators do not require phosphorylation or communication 
between proteins 67. Thousands of bacterial proteins share motifs with the AraC 
regulator but none have been found in eukaryotes 67. An example of this sort of 
protein in mycbacteria is the iron dependent regulator IdeR. The protein contains an 
N terminal helix turn helix motif for DNA binding and two metal binding sites 
surrounded by the dimerization domain 68. When bound to iron, the protein represses 
the fxbA gene product 79-81, which is an important enzyme in the synthesis of the M. 
smegmatis siderophore exochelin 69, and activates iron storage gene bfrA 70. The 
ability to acquire and store iron is very important during intracellular infection and is 
noted as a virulence factor for M. tuberculosis 82, 83. The ideR gene has been 
deemed essential 71, probably because loss of this gene product results in an 
overload of iron accumulation which is toxic to the organism 72. 
Chapter One: General Introduction 
25 
 
Serine Threonine Kinases  
The first mycobacterial serine threonine protein kinase (STPK) was discovered in 
1997 73, since then 11 Mycobacterial STPKs have been identified named Pkn A to L, 
which are implicated in development, pathogenicity and stress responses 74. STPKs 
are often implicated in development from one state to another such as in sporulation 
of M. xanthus 75. They are also thought to interfere with Mitogen Activated Protein 
(MAP) kinases of epithelial cells in Listeria monocytogenes 76. Mycobacteria, 
especially M. marinum, have a large number of STPKs; it is possible that they are 
complementing a relatively smaller number of TCS compared with other bacteria 77. 
PknG and PknK are the only M. tuberculosis STPKs that do not posses 
transmembrane regions, all the other STPKs are grouped based on homology 
clusters or function.   
Adenylyl cyclases and diguanylyl cyclases 
Other transcriptional regulators are influenced by global regulators such as cyclic 
nucleotides cyclic adenosine monophosphate  (cAMP) and cyclic diguanosine 
monophosphate (c-di-GMP). Bai et al have shown that cAMP has an important role 
in macrophage interaction as its concentration increases 50 fold during M. 
tuberculosis and M. bovis BCG infection 78. At least 15 class III adenylyl cyclases 
exist in M. tuberculosis and 31 in M. leprae, a relatively high number compared with 
other bacterial genomes 79, 80.  
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1.3.2 Prokaryote Two Component Signal Transduction 
The concept of two component signal transduction, whereby one component 
recognises some external change and another component modulates an appropriate 
response, is now a hallmark of prokaryote signal transduction.  Phosphorylation of 
histidine kinases was recognized in E.coli  by Kundig and Roseman in 1971 who 
were studying mechanisms of sugar transport 81. Later it was found that 
phosphorylation of such proteins can modulate changes in gene expression 82 when 
coupled with a response regulator in a process outlined by figure 1.3. The term two 
component system is something of a misnomer, as it includes multistep kinases with 
intermediate proteins to regulate and insulate signals 83. In E. coli there are 32 
response regulators (RR), 23 histidine kinases (HKs) and 5 hybrid sensory kinases 
83. These were identified by Mizuno et al using OmpR, NarL, NtrC and CheY 
systems as probes to search for similar open reading frames 83. They described a 
number of common “signature sequences” of HKs and RRs. 
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Figure 1.2: Two Component Signal Transduction.  Prokaryote two component systems. 
Signals are relayed from membrane bound Histidine Kinase to Response Regulator via 
phosphorylation of conserved amino acids  . Apart from ligand-specific binding domain of 
Histidine Kinase and effector domain of Response Regulator, many regions of these 
systems are well conserved among prokaryotes. 
1.3.3 Mechanisms of two component signalling 
Histidine kinases possess diverse sensing domains as well as a number of 
conserved transmitter domains 84, 85. They have been divided into one of 11 groups 
based on their protein sequence surrounding conserved residues on their transmitter 
domain namely the H box, N box, D box, F box and G box 85. The HK usually 
includes one to five N terminal transmembrane regions responsible for ligand binding 
86. This part of the protein can also be periplasmic, or intracellular and connected to 
other transmembrane receptors 85.  
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As mentioned, this part of the protein is extremely variable amongst TCS. Some 
studies have shown the sensory domain to have a specific ligand binding preference, 
such as divalent cations 87, others imply that certain conditions lead to a change in 
conformation of the protein 88. In either case, this results in an ATP-dependent 
autophosphorylation of the H box of the protein. The HKs occur as dimers with 
catalytic domains connected by a HAMP linker motif 84. The catalytic domain forms a 
complex with a cognate RR containing a conserved aspartate residue 89. The 
phosphoryl group is transferred from the histidine to the aspartate residues resulting 
in a switch to the RR’s active state 89.  
The RR usually contains around 120 amino acids, including the crucial aspartate and 
two other conserved residues 83. The RR carboxy terminal effector domain is 
responsible for initiating the cellular responses to the ligand 83. OmpR, NarL and 
NtrC type RRs have DNA binding domains and act as transcription factors in that 
they directly induce or repress gene expression 83. Others have an enzymatic role in 
the cell or directly interact with other proteins 85.  
There are essentially four steps common to all TCS which are illustrated in figure 
1.3. An environmental stimulus is recognised, usually in the form of ligand binding. 
This results in a conformational change to the HK, causing autophosphorylation of 
the histidine residue of the HK transmitter domain by the conversion of an ATP to 
ADP (adenosine diphosphate). Then there is a transfer of the phosphoryl group from 
a histidine residue on the HK to an aspartate residue on a response regulator, and 
finally dephosphorylation of the phosphoryl group to inorganic phosphate 89.  
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This is a simplified model of this mechanism because there are a number of 
variations on this theme. Some systems involve intermediate steps for greater 
control and networking between signals. Multi-step phosphotransfer signalling works 
on the same principles as two component signalling, with an added level of 
complexity. HPts are histidine containing phosphotransfer domains found in some 
signalling systems 84. This higher level of complexity is often found in eukaryote 
signalling systems, either to ensure that there are multiple regulatory checkpoints, to 
amplify a signal or so that the HPt can be an alternate target 84.   
1.3.4 Cross talk and Networks in TCS Signal Transduction 
As well as having intermediate proteins, these systems can form networks to 
integrate signal transduction 90. Pathways can be branched, in other words one HK 
can phosphorylate many RRs, such as is the case in the CheA/CheY/CheB system 
or multiple HKs can phosphorylate one RR 91. It is somewhat surprising, given the 
conserved mechanism of phosphotransfer across signalling networks, that crosstalk 
is not a problem 91. Since there are often dozens of these systems in a cell, 
responding to a vast array of different signals, it is important that these 
phosphorelays are insulated from each other. There is evidence that, in the absence 
of their cognate HK, a RR can be phosphorylated by other HKS  91. For example, in a 
PhoR deletion mutant, its native RR PhoB can be phosphorylated by another HK 
named VanS 91. Another way to induce cross talk of signals is to over-express the 
HK, presumably making the protein more likely to phosphorylate another RR. This 
has not been shown in wild type cells, indicating that there is a high level of control 
over signal insulation. It is likely that RRs, which are generally more abundant in the 
cell than their cognate HKs, have a preference for their own HK 90, 91. Also, the 
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observation that HKs often negatively control RRs by de phosphorylation means that 
there is a smaller chance of signals going astray 91. 
In eukaryotic Arabidopsis thaliana, a TCS network has been analysed giving a map 
of hundreds of interactions between proteins involved in these systems 92. A similar 
study in E. coli concluded that the most significant interaction between TCS was in 
the overlap of gene expression resulting from different systems 93, 94.  
1.3.5 The Importance of TCSs in Prokaryotes 
The signal relays described usually culminate in an alteration of gene expression. 
Large numbers of genes are either switched on or off as a result of the RR 
activation. Control of cell osmolarity in E. coli by EnvZ/ OmpR is a well understood 
example of how the cell is capable of maintaining turgor pressure 84. Controlling the 
expression of membrane proteins OmpC (during high osmolarity) and OmpF (during 
low osmolarity) is crucial in a changing environment 84.  
As well as general survival of the cell in harsh conditions, pathogenic bacteria also 
use these signal systems to express virulence factors, some of which are shown 89 in 
table 1.1.  
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TCS  Species Response 
PilS/PilR P. aeroginosa Pilus production 
FleS/FleR P. aeroginosa Adhesion 
KinA/KinB/SpoF B. subtilis Sporulation 
PhoP/PhoQ S. typhimurum Pathogenesis 
PhoP/PhoR E.coli Phosphate sensing 
Table 1.1: Virulence and survival associated TCS in prokaryotes. (as reviewed by 
Fontan 2004 89) 
 Another concern is the ability of certain TCS to induce drug resistance in a 
pathogen. Polymixin resistance in Salmonella typhimurium for example is aided by 
its PhoP/PhoQ TCS, which senses membrane disturbances and activates lipid A 
modifications to evade to the effects of the drug on the cell 95.  Another example is E. 
coli’s ability to alter gene expression under the control of the OmpF/ OmpC system 
which mediates entry of tetracycline to the cell 95. Vancomycin resistance is seen in 
Enterococcus faecalis and Staphylococcus aureus as a result of the VanS/ VanR  
and VncS/ VncR systems respectively 95, 96. Vancomycin binds to precursors in 
peptidoglycan synthesis preventing cell wall assembly 96. The VanS/ VanR system is 
able to modify peptidoglycans giving them a lower affinity for the drug 97.  
The fact that various TCS have been deemed essential to the organism is another 
reason they would make potential drug targets; to date Cck/ CtrA of Caulobacter 
crescentus, MtrB/ MtrA of Mycobacterium tuberculosis, HP166/ HP165 of 
Helicobacter pylori and YycG/YycF  of Bacillus subtilis and Streptococcus 
pneumonia are considered to be essential 98. 
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1.4 Two Component Systems in mycobacteria 
The M. tuberculosis genome encodes 11 TCS and seven orphan HKs and RRs 86. 
All of these belong to either the OmpR or NarL family of TCS defined by the residues 
surrounding their H box. M. bovis shares all of these TCS while the M. smegmatis 
genome contains five out of the seven orphan HK and RR and nine out of the eleven 
complete TCS 86. Table 1.2 names all of these systems and their M. smegmatis 
homologues with any known conditions regarding their expression, based on articles 
by Tyagi, Fontan and Haydel  113, 116, 125. These TCS are found in a majority of 
mycobacterial species, with the exception of M. leprae which has only 4 out of 12; 
SenX3/ RegX3, PrrB/ PrrA, MprA/ MprB and MtrB/ MtrA. 
Some of the TCS of M. tuberculosis have been well studied and their activating 
factor or factors proposed. Others have been shown to be upregulated during intra-
macrophage infection, indicating an important function during infection and latency, 
but the specific condition they are responsive to remains elusive. The systems used 
in this study were MtrB/ MtrA, DevS/ DevR and SenX3/ RegX3 which will be 
described.. 
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Name (HK/ RR) Gene  M.Smegmatis 
homologue 
Similarity Proposed 
function 
SenX3/ RegX3 Rv0490/ 
Rv0491 
MSMEG_0936 
MSMEG_0937 
0.695 
0.933 
Phosphate 
starvation  
KdpE/ KdpD Rv1028/ 
Rv1027 
MSMEG_5395 
MSMEG_5396 
0.773 
0.858 
Nutrient 
starvation 
MprB/ MprA Rv0982/ 
Rv0981 
MSMEG_5487 
MSMEG_5488 
0.763 
0.9 
 
MtrB/ MtrA Rv3245/ 
Rv3246 
MSMEG_1875 
MSMEG_1874 
0.828 
0.969 
Iron 
starvation 
PrrB/ PrrA Rv0902/ 
Rv0903 
MSMEG_5663 
MSMEG_5662 
0.813 
0.932 
 
TrcS/ TcrR Rv1033/ 
Rv1032 
MSMEG_2916 
MSMEG_2915 
0.715 
0.507 
 
DevS/ DevR* Rv3133/ 
Rv3132 
MSMEG_5244 
MSMEG_5241 
0.852 
0.664 
Hypoxia, 
nitric oxide 
PhoP/ PhoR Rv0758/ 
Rv0757 
MSMEG_5870 
MSMEG_5872 
0.798 
0.927 
 
TcrY/ TcrX Rv3765/ 
Rv3764 
MSMEG_4989 
MSMEG_4990 
0.589 
0.859 
 
NarL/ NarS 
(NarL family) 
Rv0844/ 
Rv0845 
MSMEG_0105 
- 
0.781  
TcrA/-/- 
 
Rv0600-Rv0602 -   
Orphan RR, 
NasT 
Rv1626 MSMEG_3246 0.872  
Orphan RR 
 
Rv0260c MSMEG_0432 0.747  
Orphan RR 
 
Rv0818 MSMEG_5784 0.747  
Orphan RR  
 
Rv3143 MSMEG_2064 0.736  
Orphan RR 
 
Rv2884 -   
Orphan HK 
 
Rv3220 MSMEG_1918 0.757  
Orphan HK 
 
Rv2027c -   
 Table 1.2: HKs and RR of M. tuberculosis. (All HKs belong to the OmpR  family except * 
which is a NarL type HK)  
1.4.2 1.4.1 MtrB/ MtrA 
The first TCS to be discovered in M. tuberculosis was the MtrB/MtrA system 99. Curic 
et al used a xylE promoter fusion reporter system to show that the mtrA gene 
expression varied depending on the media used to culture M. smegmatis and M. 
bovis 99. Another group used a Green Fluorescent Protein (GFP) promoter fusion to 
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show this gene was expressed during macrophage infection with M. bovis BCG 127 
which was later complemented by work from Via and co-workers 100. One interesting 
quality of this TCS is the fact that it has not been knocked out, indicating that it may 
be essential to M. tuberculosis 101. This has however made it more difficult to 
investigate its function during infection. In 2006 a group over expressed the MtrA RR 
showing that overproduction of this protein prevented multiplication during 
macrophage infection, but not in broth 102. They concluded that the ratio of 
phosphorylated to unphosphorylated MtrA was vital for intra macrophage replication, 
since simultaneously upregulating its HK MtrB had no effect 102.They supported this 
theory by showing that MtrA binds to the promoter of a replication gene dnaA 102. 
They also suggested that it may be involved in the AFB’s ability to block 
phagolysome fusion. Friedland et al solved the crystal structure of MtrA and 
demonstrated that it was similar to the PrrA RR and may have multiple 
conformations 103. 
 Studies of this RR in other species may also give clues as to its function in M. 
tuberculosis. A study of M. leprae cell wall associated proteins unearthed an mtrA 
homologue in this species, highlighting its importance for intracellular growth 104. In 
M. avium the mtrB locus has been knocked out using transposon mutagenesis, 
resulting in a strain with attenuated virulence which cannot make the red white 
switch on Congo red agar 105. In this species the TCS is required for the control of 
cell surface proteins and regulates permeability and composition of cell wall 
components 105. In a more distantly related species Cornebacterium glutamicum an 
MtrA knockout showed an effect on antibiotic susceptibility and osmo-regulation of 
the cell 106. In this species the mtrA gene is probably involved in peptidoglycan 
metabolism and osmotic protection 106. Interestingly, a similar TCS the AmrA/ AmkA 
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system of Amycolatopsis mediterranei has been knocked out showing a 20% 
decrease in RIF production by the organism 107. 
MtrB/ MtrA is well conserved in other mycobacterial species including M. smegmatis, 
which makes this system easy to manipulate for this study. Since MtrB/ MtrA 
appears to be induced during macrophage entry and has not yet been knocked out, 
this system shows great potential as a drug target in M. tuberculosis.      
1.4.2 SenX3/ RegX3 
The SenX3/ RegX3 TCS has been well characterised in M. tuberculosis 135-137. It is 
involved in the phosphate transport system and induces the M.smegmatis  phoA 
gene, whose protein product is an alkaline phosphatase required for transport of 
inorganic phosphate into the cell 108. It is proposed that this system controls the 
regulation of around 50 genes as well as the regX3 gene product 109. This positive 
autoregulation of the RR is important in TCS for signal amplification 110. The phoA 
gene is present in M. smegmatis and E. coli but not M. tuberculosis 111. This gene is 
involved in inorganic phosphate transport in E. coli, a mechanism which has been 
well characterised in this species 135, 139, 140. PhoA is induced by SenX3/ RegX3 in M. 
smegmatis and by PhoP/ PhoR in E.coli in a phosphate dependent manner 135, 139. It 
functions as a cell surface associated lipoprotein which liberates inorganic 
phosphate from macromolecules 111.  
The phosphate specific transporter PST and phosphate intake transporter PIT  are 
responsible for maintaining cellular levels of inorganic phosphate 111. The PST 
proteins act as a sensor of phosphate concentration, keeping RegX3 in an 
unphosphorylated state 108. When phosphate is limited the PST complex causes 
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dimerization of the SenX3 HK, which activates the RegX3 RR to induce phoA and 
other genes required for phosphate production 108.  
To summarise, this TCS is implicated in the phosphate transport system, its 
expression is  increased during early macrophage infection 112 and its knockout 
displays attenuation of growth in a mouse and macrophage model. This suggests 
that this TCS may be an important virulence factor 109. Specific sequence differences 
between virulent and avirulent strains of the M. tuberculosis complex species have 
been shown in the sequences of this TCS, indicating that virulence phenotypes may 
be affected by SenX3/ RegX3 113.   
1.4.3 DevS/ DevR 
The DevS/ DevR system is responsible for inducing the dormancy response of M. 
tuberculosis during hypoxia and nitric oxide stress 71, 72, 142-144 making it a valuable 
target in preventing latency 114. Unlike most other TCS of M. tuberculosis, the DevS/ 
DevR system is part of the NarS/ NarL family 89. The DevS HK contains two GAF 
domains in its sensing core named GAF A and GAF B 115. It has been proposed that 
GAF A binds to heme which changes from an oxygenated to a deoxygenated state 
during oxygen starvation, this results in DevR activation and transcription of a 
number of dormancy related genes 115. This assumption was based on the 
observation that cyanide, which binds with heme, hinders the dormancy response in 
M. tuberculosis usually induced by nitric oxide stress and oxygen starvation. The 
importance of this TCS during hypoxic stress has been illustrated by its knockout 
mutant, which cannot survive oxygen starvation and is more sensitive to heat shock 
62. As previously mentioned, the granumloma formed in the human lung during M. 
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tuberculosis infection leaves the AFB in a hypoxic environment 116. It is proposed 
that this oxygen based sensor could be a switch from aerobic to anaerobic 
metabolism.  
A mouse model has shown knockouts of this system to be hyper virulent 112 while 
rabbit and guinea pig models show it is required for persistence 117. Converse et al 
117 showed marked differences in results depending on the model host used. 
Considering the different pathology shown in different host organisms, it is possible 
the DevS/ DevR system is required to shut down active metabolism and therefore 
the knockout appears hyper virulent in mice because this host does not naturally 
show latency.  
During the M. tuberculosis dormancy period a number of genes required for active 
metabolism are repressed, while stress response genes, including hspX, are induced 
47, 144, 148. The hspX gene product is an alpha crystallin antigen which may play a role 
in stabilizing proteins during persistence 63. As well as hspX, DevS/ DevR induces 3 
universal stress proteins (UspL,M and N) and a nitroreductase (Rv3131) 118.    
The signal transduction mechanisms of M. tuberculosis undoubtedly have an overall 
effect on its virulence and pathogenesis, in particular the switch from active to latent 
infection. It is in this light that these systems are viewed as excellent potential drug 
targets in mycobacteria and other pathogenic prokaryotes. Consequently, a number 
of groups have attempted to develop inhibitors to these signalling systems.   
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1.4.4 Two Component Systems as Drug Targets 
The search for new anti-TB drugs is a particularly important component of the STOP 
TB strategy, given the rising threat of MDR and XDR-TB. Using growth inhibition 
assays to discover anti-tubercular agents from a vast array of compounds by 
measuring the effect on the whole cell, may lead to the discovery of effective agents 
against the pathogen. On the other hand, a more targeted approach to specific 
components of the cells dormancy program is more likely to yield an agent with a 
detrimental effect on M. tuberculosis during a latent TB infection.  
Since the discovery of TCS and their inferences to virulence and persistence, they 
have been labelled as critical targets in pathogenic bacteria 98. Generally speaking 
signal transduction mechanisms allow bacteria to persist and cause disease in a 
human host; TCSs in particular are of great interest for four main reasons 98: 
 Their ubiquity among prokaryote organisms and selective presence in higher  
eukaryotes, indicates a TCS inhibitor would be less likely to exert a negative effect 
on a human host 
 Principle active sites in TCS display a high level of homology, so a TCSi could 
potentially act on a number of TCS across a broad spectrum of bacteria  
 At least four TCS are essential to their host organisms 
 TCS are often used by prokaryotes to regulate the expression of virulence 
factors 
More specifically, in terms of M. tuberculosis, current drug targets act on processes 
such as cell wall and protein assembly, which are only effective in the case of an 
active TB infection. In targeting the mechanisms M. tuberculosis employs to sustain 
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an ongoing latent infection, problems encountered with many of the current anti-TB 
agents such as toxicity, lengthy treatment duration and the emergence of resistant 
strains could be prevented 114.  
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1.5 Inhibitors of TCS 
There are multiple stages of the TCS phosphorelay that could be targeted to inhibit 
this type of signal transduction 119. Figure 1.3 shows some of the reactions of the 
phosphorelay which could potentially be inhibited as well as examples of known TCS 
inhibitors and their proposed targets. In theory, targeting a conserved mechanism 
such as the phospho transfer between the histidine and aspartate would give rise to 
a broad spectrum inhibitor. On the other hand, targeting a specific ligand binding 
mechanism of the HK, or DNA binding of the RR, would render TCSi that is fairly 
specific to that TCS.  
 
 
 
 
 
 
 
 
The specificity of a TCS inhibitor would depend on which part of the relay is targeted. 
Interfering with conserved domains involved in general phosphotransfer would give  
Figure 1.3: TCS Inhibitors. A summary of known TCSi and their proposed mechanisms of 
action. Agents have been found which inhibit a number of the steps involved in TCS signal 
transduction including ligand binding to HK, ATP hydrolysis, HK dimerization and RR 
phosphotransfer and promoter binding. 
ATP hydrolysis:  
 AranorosinolB 
 AMP-PMP 
 TEP 
Hpt domain 
phosphotransfer: Sda 
RR binding to promoter 
regions of TCS 
controlled gene: D897 
ATP  ADP  
HK dimerization:  
 Closantel 
 RWJ-49815 
Ligand Binding:  
 AIP  
 KipI  
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To date there have been a number of compounds introduced to the field which act 
on specific components of the signal transduction machinery, but none that do so in 
a way that affects signalling independently of other prokaryote and eukaryote cellular 
processes 98.  
1.5.1 Inhibition of the Histidine Kinase 
Compounds which affect ligand binding to HK sensor domains have been developed 
for specific targets 98. These are usually derivatives of naturally occurring ligands 
which are modified at specific residues in order to compete with naturally occurring 
ligands of the TCS.  
Streptomyces produce autoinducing peptide (AIP) to induce virulence factor Agr 
required for quorum sensing 119.  When the population reaches a threshold density, 
secretion of AIP binds the HK of the ArgC/ ArgA TCS effectively inducing virulence 
genes and repressing surface proteins 119. Replacing the sulphur of the thiolactone 
ring structure of AIP with O or N provides a competitive inhibitor of their quorum 
sensing mechanism 119.   
KipI is a protein inhibitor of B. subtilis sporulation TCS KinA/SpoOA 120. This protein 
inhibits the autophosphorylation of KinA, but not the phospho transfer step. Another 
gene in its operon, kipA, counters its activity 120. 
A number of chemicals have been found to inhibit the ATP to ADP hydrolysis shown 
in figure 1.4. These can act in either a competitive or non competitive fashion. AMP-
PNP (adenosine monophosphate p-Nitrophenol), TEP (triethyl phosphate) and 
aranorosinol B for instance competitively inhibit this hydrolysis reaction while cis 
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unsaturated fatty acids such as oleic and palmitoleic act in a non competitive fashion 
98. While they effectively inhibit this signal transduction process, they would clearly 
affect a number of other processes in both the host and pathogen.  
Most TCS inhibitors to date interfere with the dimerization domain of a HK, exposing 
hydrophobic amino acids resulting in an aggregation of HKs at the cell membrane 
121. Closantel and RWJ-49815 act in this way, denaturing the dimer of KinA by 
interfering with its 4 helix bundle between the sensor and effecter domains 122. 
Without suitable dimerization, signal transduction cannot be relayed to the RR. 
These compounds have the same effect in a sensor kinase in E. coli reflecting a 
broad spectrum of activity 96. Unfortunately, many of these HK dimerization inhibitors 
also have an effect on membrane intergrity in both bacterial and mammalian cells 
and thus have not been developed as antibiotics. 
The Sda protein inhibits the sporulation system KinA/KinB through binding of the 
histidine phosphotranfer domain (HPt) of KinB 121. This compound binds with the 
alpha helices, not the conserved H box or catalytic domain, and acts as a molecular 
barricade, hindering communication between KinB and KinA 121.  
1.5.2 Inhibition of Response Regulator 
A less common mechanism of action is the inhibition of the RR activity. A modified 
protein can alter a HK/ RR interaction via competition for their binding site. 
Modifications to the DrrA peptide of the HpkA/DrrA system in Thermotoga maritima 
caused competitive binding for HpkA resulting in a loss of dimer formation 123. A 
compound named D897 is able to inhibit DNA binding of RR to the promoter regions 
of induced genes by preventing the dimerization of RR required for DNA binding 98. 
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Although natural and synthetic compounds have been shown to inhibit stages of this 
process, research in the field has yet to provide a compound which affects these 
processes exclusively. A major shortcoming of many TCS inhibitors described is an 
adverse effect on membrane integrity of both bacterial and human cell membranes 
98. A study of 24 TCS inhibitors showed that 23/24 had adverse effects on membrane 
integrity. This suggests  that their activity may be the result of  another mechanism 
altogether, such as membrane interference or macromolecule synthesis 124. 
Unfortunately the only compound free of this defect had a relatively high minimum 
inhibitory concentration (MIC) 124. Other TCS inhibitors exhibit severe toxic side 
effects, closantel for example adversely affects energy metabolism in the 
mitochondria 125.  
That being said, the organism Staphylococcus epidermis causes major problems 
with its ability to form biofilms on medical instruments 126. It has been suggested that 
an inhibitor of the YycG HK of this organism, required for biofilm formation, could 
easily be used as a sterilization agent on medical equipment if it were cost effective 
126. Another suggestion is the use of non toxic HK inhibitors in combination with other 
drugs to improve a therapeutic outcome. Isothiazolone and imidazolin salts were the 
first TCS inhibitors to be discovered 127. These aromatic structures showed activity 
against the AlgR2/ AlgR1 system, an important virulence factor of P. aeroginosa 
which causes major problems in cystic fibrosis patients 127. These could be used to 
improve the therapeutic outcome of patients with cystic fibrosis 98 even though they 
do no inhibit the organism outright. Despite work by several groups to discover and 
develop TCS inhibitors, none been made commercially available as antibiotics or 
bacteriostatic agents in a medical context. The aim of this study was to develop a 
way in which one can screen for novel TCSi, which inhibit mycobacterial signal 
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transduction exclusively of other cellular processes, by incorporating a whole cell 
based approach as opposed to inhibiting individual proteins.   
1.5.3 Screening for TCS inhibitors 
High throughput screening (HTS) methods allow researchers to test thousands of 
compounds at a time for activity against TCS. There are two approaches here, either 
random screening of a large number of compounds from a library 119 or rational 
design using virtual screening methods based on the crystal structure of a target 
protein 126. The latter method allows one to screen a much larger database of 
compounds, however all hits must be validated by another method to show that the 
compound specifically inhibits the putative target in vitro. 
A direct approach involves the use of purified, truncated or altered HK to screen for 
specific inhibitors. Inhibition can be demonstrated using radio labelled phosphate as 
a donor in the ATP dependent  autophosphorylation of purified HKs and RR 98, 128. 
This sort of assay has been established by Saini et al with M. tuberculosis DevS 
/DevR system proteins 128. The Taz-1 assay was used to find inhibitors of the EnvZ/ 
OmpR system 129. In this screen the HK receptor signal is replaced by an aspartate 
chemoreceptor which stimulates autophosphorylation of the HK in the presence of 
aspartate. A lacZ promoter fusion of the ompC gene was also used to determine 
OmpR binding to this DNA region 129, 130. The homodimerization assay exploits the 
capacity of certain truncated HKs to dimerise in vitro 98. Using a plasmid with GFP 
under the control of the E. coli  iclR promoter, truncated Yyc proteins expressed with 
the IclR repressor can only induce GFP expression when present as a dimer 98.  
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These sophisticated screening methods are limited in that they deal with altered 
forms of proteins which do not naturally occur in the cell. Using the native forms of 
these proteins in a whole cell based assay may deliver TCS inhibitors which 
represent a higher level of efficiency in a whole cell model. 
Whole cell based methods have a number of advantages over isolated protein 
methods . For one thing, TCS inhibitors found using protein based methods may be 
potent inhibitors of signal transduction, but their ability to permeate the cell 
membrane is not taken into account. What is more, other metabolic activities of the 
cell are accounted for, such as proteins and enzymes which could decrease the 
activity of these compounds. As previously mentioned, all of the current known TCSi 
have failed in that they cause adverse affects on bacterial and mammalian cell walls. 
Many bacterial species also have efflux pumps which could potentially remove these 
inhibitors from the cell before it reaches its target. 
Another consideration is the specificity of the target. Using isolated protein methods 
confines the researcher to finding inhibitors of a specific molecule or reaction in the 
chain of events involved in signal transduction. Using a whole cell based method, 
which measures the end result of the signalling mechanism, i.e. the up-regulation of 
a particular gene under the control of that system, increases the likelihood of an 
inhibitor of any part of this phosphorelay being picked up in the screen. 
 In 1993 Roychoudhury et al discovered the first TCSi by screening around 25,000 
synthetic compounds using a whole cell xylE reporter system assay 127. Inhibition of 
the RR binding activity to the algD promoter was demonstrated in 15 compounds 
using this colourmetric assay 127. Differential growth assays are another method that 
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can be applied to whole cell screening. Temperature sensitive mutants of the YycG 
HK showed hypersensitivity to 11 compounds in a screen of 4000 acetone extracts 
131. These hits were further characterised, leading to the detection of aranorosinol 
B’s ability to inhibit the autophosphorylation of YycG in S. aureus and B. subtilis 131.  
Measuring expression of a TCS target gene is a valuable method because it 
accounts for everything that is going on in the cell at once. These methods show that 
a compound is capable of reaching its target and that gene expression is being 
inhibited in spite of whatever else is going on in the cell. However, it is an indirect 
method of detecting TCS inhibition. Usually validation either at a protein level or by 
measuring the expression of an unrelated gene is required in order to show that a 
compound does not simply have a global effect on gene expression. It is also 
important to consider any implications that reporter systems may have on both the 
cell and compounds in the screen and vice versa.  
In this study a GFP reporter was used to measure the expression of promoters under 
the control of mycobacterial TCS to evaluate conditions which induce these systems 
and screen for TCS inhibitors using available drug libraries.  
1.5.4 Methods used in this Study 
The aim of this study was to apply a promoter reporter method to demonstrate 
appropriate conditions under which selected TCS genes are induced, so they can be 
used in a screen for two component system inhibitors. GFP, isolated from Aequorea 
victoria, has been used to monitor gene expression since 1994 132, 133. It is an ideal 
reporter as it does not require substrate activation 133 and numerous enhanced 
variants of the original wildtype GFP exist for specific purposes 134-136. GFP mut2 will 
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be used to scrutinise the expression of TCS-regulated genes, and examine changes 
that occur to these expression profiles as a result of exposure to compound libraries. 
The constitutively expressed hsp60 promoter will be included to verify that a shift in 
GFP fluorescence is the result of some mechanism other than a reduction in global 
gene expression on the cell. The model organism M. smegmatis will be used so that 
these assays can be carried out to test as many compounds as possible in a high 
throughput manner as it grows more rapidly and can be safely manipulated in a PC2 
laboratory. The resultant experimental procedure could lead to further studies of the 
more pathologically relevant M. bovis BCG once the assay is optimised for M. 
smegmatis.  
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1.6 Aims 
The overall objective of this research was to design a screen which identifies 
inhibitors of mycobacterial TCS related to dormancy and intra macrophage survival. 
This required four main objectives to be carried out: 
1. Create a list of suitable M. tuberculosis and M. smegmatis TCS dependent 
genes and identify their promoter sequences. 
2. Clone these promoter sequences and an optimised GFP reporter gene into a 
plasmid which can be electroporated into M. smegmatis. 
3. Demonstrate conditions under which the greatest expression of these 
promoters is found.  
4. Develop a bioassay to screen compounds for mycobacterial TCS inhibitors 
based on the expression of these TCS regulated genes.  
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2.1 Strains and culture conditions 
The plasmid construction was carried out in E. coli DH5α grown in Luria Broth (LB) 
or on Luria agar (LA) from Sigma Aldrich, with either kan50  (kanamycin 50 µg/ml) or 
amp200 (ampicillin 200 µg/ml). M. smegmatis MC
2 155 was growth on LA or in LB 
supplemented with 0.1 % Tween 80 and 1 % D- arabinose or Hartmans deBonts 
(HdeB) minimal media as described 53 using kan50 for plasmid selection. Further 
modification to culture media for stress condition assays shall be discussed in 
section 2.6.  
2.2 Plasmids and Primers 
This work involved the use of a number of published and unpublished plasmids from 
various sources as well as the creation of a new pSHigh construct. The plasmids are 
briefly described and their sources displayed in table 2.1. Primers used to clone and 
sequence elements of the new reporter construct are displayed in table 2.2.   
Plasmids 
pcr 2.1 
pLUG 
pTKmx 
pHS201 
pOT11 
pOT71 
pOT72 
pOT62 
pSHigh 
pHigh100 
Description 
TA cloning vector, Ampr , Kanr 
TA cloning vector, Ampr 
pAL500, pUCori, Kanr, xylE 
Phsp60, GFPmut2, oriM high, pUCori, Kan
r 
Ptet, GFPmut2, pMMB207 backbone 
Phsp60GFPmut2, pAL5000, pUCori, Kan
r 
Phsp60HSP60, GFPmut2, pAL5000, pUCori Kan
r 
Phsp60, GFP RBS, GFPmut2, pAL5000, pUCori, Kan
r 
GFP RBS, GFPmut2, oriM high, pUCori, Kanr 
GFPmut2, oriM high, pUCori, Kanr 
Source 
Invitrogen 
Bioline 
137  
138 
139  
O’Toole (unpublished) 
O’Toole (unpublished) 
O’Toole (unpublished) 
This study 
138 
Table 2.1: Plasmids used in this study. 
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Primer Name 
GFP(RBS)_F 
GFP_R 
oriM_F 
oriM_R 
M. tuberculosis promoters 
Phsp60 Rv0440_F 
Phsp60 Rv0440_R 
PhspX Rv2031c_F 
PhspX Rv2031c_R 
M. smegmatis promoters 
PMtrA MSMEG_1872 _F 
PMtrA MSMEG_1872 _R  
PphoA MSMEG_1012_F 
PphoA MSMEG_1012_R 
PhspX MSMEG_3932_F 
PhspX MSMEG_3932_F 
Sequencing Primers 
oriM(-100)_F 
oriM(+600)_F 
oriM(-100)_R 
oriM(+600)_R 
pTKmx_F 
Sequence 
GGGGGGTACCTTTAAGAAGATATACATATGAGTAAAGGAGAA 
GGGGGCATGCTTATTATTTGTATAGTTCATCCATGCC 
GGGGGCTAGCAACGAGGACAGTCGCACGAC 
GGGGGCTAGCAT CGAGCCGAGAACGTTATC 
 
GGGGGAATTCCGCACCGAGTCCAGCGAG 
GGGGGGATCCGCAATTGTCTTGGCCATTGCG 
GGGGGAATTCTCGGTACGGCGCAGTAGGAT 
GGGGGGATCCAAACTCGGGGAAGAGGGACC 
 
GGGGGGTACCCGAGACCAACCACAA 
GGGGGGTACCTCCATGGTGTCACCA 
GGGGGGTACCCAGCCGTGCAGACCA 
GGGGGGTACCCAGCCGTGCAGACCA 
GGGGGGTACCAACCGTGCGGCACGGGGAGATCTG 
GGGGGGTACCTTCAGGAAGTTTGGTCATCGGTCCTCCTCA 
 
GGGGAACTTAATCGCCTTGCAGCA 
GGGGCCTGTTCTGCCGCACGCTCT 
CCCCCCAGATAGCCCAGTAGCTG 
CCCCCAGGTGGTTGGGGGTGCTCG 
 
Table 2.2: Primers used in this study. Restriction sites of primers are underlined  
 
2.3 Identification of TCS dependent genes in M. tuberculosis and 
M. smegmatis 
A list of candidate M. tuberculosis and M. smegmatis TCS controlled genes was 
established after a literature search based on the following criteria: 
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1. The candidate must contain a non-coding region upstream of the gene or 
have its promoter region identified, preferably with a gel mobility shift assay 
consistent with the ability to bind directly with a RR. 
2. Factors or conditions inducing expression of the gene should be postulated or 
proven.  
3. A high fold induction of gene expression upon stimulation, or a significant 
decrease in expression of that gene displayed in the TCS mutant. 
Sequences of candidate genes and their organisation within an operon were 
obtained from www.genome.jp. A promoter region of approximately 600 base pairs 
was selected directly upstream of each candidate gene for primer design. 
 
2.4 Plasmid Manipulation 
Cloning procedures were carried out with T4 ligase from Bioline and restriction 
enzymes and their respective buffer solutions from New England Biolabs (NEB). 
Polymerase chain reactions (PCR) were carried out with Taq polymerases from 
either Bioline or Invitrogen limited. 
2.4.1 Amplification of Promoters from Genomic DNA 
Genomic DNA (gDNA) from heat treated M. tuberculosis H37Rv was provided by 
AgResearch (Upper Hutt). M. smegmatis gDNA was prepared by standard genomic 
preparation as described by Sambrook 140. Primers were designed to amplify around 
600 base pairs of a promoter region upstream of each gene of interest, including at 
least the start codon of each gene. Primers contained EcoRI and BamHI restriction 
sites for cloning into low copy number pOT constructs, or KpnI for cloning into 
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pSHigh constructs. In addition, the highly conserved promoter of the hsp60 gene 
(Rv0440) was cloned as a constitutively expressed positive control. Promoters were 
amplified from gDNA using the high fidelity polymerase Platinum Taq (Invitrogen 
Ltd.) according to manufacturer’s instructions with an Eppendorf thermocycler. 
Appendix 1 displays a summary of all PCR conditions used in this study. PCR 
products were visualised on a 1% agarose gel to check they were the correct size, 
before the PCR products were isolated using a clean and concentrate kit from Zymo 
Ltd.  
2.4.2 Ligation of promoters into Cloning Vectors and heat shock 
Transformation into E.coli  
Purified PCR products were ligated into either pCR2.1 of pLUG TA cloning vectors 
using T4 ligase by incubating promoter, vector, ligase enzyme and 1 x ligase buffer 
for at least 4 hours at 16 oC. A summary of ligation reactions in this study is shown in 
appendix 2.   
Ligation reactions were then transformed into calcium competent E. coli DH5α by 
heat shock transformation. For notes on preparation of calcium competent DH5α see 
appendix 4. The optimal ratio of cells to ligation product is 10:1 so for a 10 µL ligation 
reaction, aliquots of 100 µL of DH5α cells were used. Cells were first thawed on ice 
for 5 minutes before adding the ligation product. Following a 20 minute incubation 
period on ice, cells were heat shocked at 42 oC in a heat block for 2 minutes and 
then returned to ice for 5 minutes. The cells were then recovered at 37 oC without 
agitation, for at least 45 minutes in 600 µL of LB, without antibiotics, to allow 
expression of the antibiotic cassettes contained on the plasmid. Following recovery, 
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cells were centrifuged for 30 seconds at 12000 rpm and the supernatant removed to 
leave 100 µL of cells which were re-suspending by gentle pipetting.  
For blue white colony selection, cells were spread on Luria agar with Isopropyl-Beta-
d-Thiogalactopyranoside (IPTG) at 100 µg/ml, X-galactosidase (Xgal) at 40 µg/ml 
and ampicillin at 200 µg/ml and incubated at 37oC overnight. At least 5 white 
colonies for each ligation reaction were selected and inoculated in 3 mL overnight 
cultures of LB with ampicillin (200 µg/ml). 600 µL from each culture was reserved for 
a -80 oC freezer stock, made with an equal volume of 80 % glycerol to give a final 
concentration of 40 % gylcerol.  
2.4.3 Plasmid Isolation and Digestion 
The remainder of the liquid culture was used for plasmid preparation. In this study 
plasmid DNA was isolated using either alkaline lysis with phenol chloroform 
extraction as described 140 or using a Zymo plasmid preparation kit according to 
manufacturer’s instructions. The pellet free Zymo kit method was preferred when 
plasmids were to be sequenced or electroporated, since this method gives a cleaner 
plasmid product. The alkaline lysis method was used when a concentrated DNA 
preparation was required, for example before removal of a fragment by restriction 
digest. 
The presence of the inserted promoter fragment was verified with a small amount of 
the plasmid preparation by a restriction enzyme digest with EcoRI. A summary of 
restriction enzyme digestions can be found in appendix 3. EcoRI sites surrounding 
the cloning region of the TA vector result in a drop-out of the fragment after digestion 
giving two distinct bands on a 1% agarose gel. Plasmid preparations which displayed 
this fragment drop out were sequenced by the Alan Wilson Centre (AWC) in 
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Palmerston North using primers M13 forward and reverse, which are present on the 
TA cloning vector surrounding the insertion site. 
2.4.4 Sequence Alignment 
Chromatogram data were analysed for fidelity using Vector NTI software (Invitrogen). 
The sequence displayed between the M13 forward and reverse primers was then 
aligned with the published sequence of the candidate promoters using AlignX 
software (Invitrogen). It was important that these sequences were accurate since the 
exact location of response regulator binding site on the promoter was not always 
known. In some cases this process was repeated until the sequence of each 
promoter was identical to the published genome. Clones with correct promoter 
sequences were identified and used to construct GFP reporter plasmids. 
2.4.5 Low Copy Number Reporter Constructs 
TCS regulated promoters were cloned into low copy number mycobacterial plasmid 
pOT71 with EcoRI and BamHI restriction enzymes sites. The reporter plasmids were 
developed based on pTKmx plasmids from Kenney et al 137. These contain a 
kanamycin resistance cassette, mycobacterial origin of replication pAL5000, E. coli 
origin of replication pUCori (also known as oriE) and gfpmut2 cloned from the pKEN 
plasmid created by Cormack et al 136 with a multiple cloning site in front of the GFP.  
Plasmid DNA of the pOT71 plasmid was digested with EcoRI and BamHI with 1 x 
BamHI buffer overnight at 37 oC. Around 3 µL of this reaction was visualised on 1 % 
agarose gel to ensure a single band was obtained. Restriction enzymes were 
removed by column purification using a Zymo clean and concentrator kit. 
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Sequenced promoters were concurrently digested out of their cloning vectors using 
the same restriction enzymes. Restriction enzyme reactions were run through a 1% 
agarose gel to separate plasmid and promoter fragments. These were then excised 
and the DNA purified using a Zymo gel extraction kit according to the manufacturer’s 
instructions. To ensure DNA was not lost in this process, the DNA was visualised by 
running a small amount of the sample on a 1% agarose gel.  
Promoters were then inserted into pOT71 by incubation with T4 ligase and T4 ligase 
buffer at 16 oC for at least 6 hours. A small amount of KpnI, which cuts between the 
two cloning sites (EcoRI and BamHI), was added to the reaction to prevent 
unwanted uncut pOT72 from remaining in the reaction. The ligation reaction was 
then transformed into DH5α by heat shock as previously described and plated on LB 
supplemented with kan50. 
The primer pTKmx F1 corresponding to a region on the plasmid about 100 bp 
upstream of the cloning site, was used  in combination with each promoter’s reverse 
primer to screen for clones with the promoter correctly inserted into the pOT71 
plasmid. This was carried out by colony PCR screen, according to the 
manufacturer’s guidelines for using Mastermix from Bioline, except that cells from a 
single colony were used as template DNA, and added using a toothpick or pipette 
tip. The same tip was then added to a 3 mL falcon tube containing LB and 
kanamycin for an overnight incubation at 37 oC. 
 
The 3 mL overnight cultures for all positive clones were used to create freezer stocks 
and plasmid preparations of the pOT71 + promoter constructs. These were then 
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sequenced using the pTKmx F primer to ensure promoters were correctly inserted in 
frame with GFP in the plasmid.  
2.4.6 High Copy Number Reporter Constructs 
While this work with the pOT71 plasmids was being carried out, Bourn et al 
published a paper on a high copy number plasmid for mycobacteria involving the use 
of a modified pAL5000 origin of replication which will henceforth be known as oriM 
high 138. They showed a seven fold increase in plasmid copy number compared with 
the original pAL5000 origin of replication. A modification of 3 base pairs, causing an 
alanine deletion, lead to a significant increase in gfp expression on their pHS201 
plasmid 138. The authors kindly gifted us this plasmid to use in our work. 
Unfortunately their plasmid contained an EcoRI site in front of the GFP, which was 
also found in their modified oriM so it was impossible to clone promoters directly into 
this plasmid. A new plasmid was constructed using their modified high copy number 
origin of replication named pSHigh.  
Initial experiments involving the pOT plasmids indicated that pOT62, containing a 
ribosomal binding site (RBS) upstream of the gfp gene, displayed a higher 
fluorescent intensity than the pOT71 plasmids. In order to include this RBS 
sequence in front of the GFP in the new plasmid pSHigh, a forward primer was 
designed to include this sequence in front of the GFP start codon. We reasoned that 
having a terminator upstream of the GFP would also improve the vector by avoiding 
leakage and unwanted GFP expression. The pTKmx plasmid contains a terminator 
site upstream of the multiple cloning site, so this plasmid was used to create the new 
high copy number vector. In summary, three improvements were made to optimise 
the potential of this plasmid as a reporter of gene expression:  
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 High copy number origin of replication (oriM high from pHS201). 
 Ribosomal binding site for GFP (added to the primer sequence). 
 Terminator site upstream of cloning site (trp from pTkmx). 
 
GFP RBS insertion 
The gfpmut2 gene, as well as its RBS, was cloned from pOT11 with GFP_RBS_F 
and GFP_R primers by PCR using a high fidelity polymerase, Platinum Taq 
(Invitrogen). As described for the TCS controlled promoters in section 2.3, this gene 
was cloned into a TA vector, sequenced and then excised with KpnI and SphI. The 
pTKmx plasmid was also digested with these enzymes to replace the xylE 
component of this plasmid with the gfpmut2 by ligation and heat shock 
transformation onto LB agar with kan50. Screening colonies of DH5α during this step 
was facilitated by briefly placing the plate on a UV light box and selecting brighter 
colonies for the PCR screen, which increased the number of positive clones 
containing the pTKMx_F and Gfp_R primed amplicon. Correct orientation was 
verified by sequencing with pTKmx F primer. 
pAL5000/ oriM high switch 
The original origin of replication was removed from pTKmx by digestion with NheI 
and separated from the rest of the plasmid by gel extraction. The high copy oriM high 
was amplified from Bourn’s pHS201 plasmid using primers oriM_F and oriM_R with 
a modified PCR protocol for amplification of long fragments (see Appendix 1).  
The PCR product was visualised on a 1 % agarose gel and then purified using a  
clean and concentrator column to remove PCR enzymes before ligation into pTKmx 
–pAL5000. Ligation products were transformed by heat shock into DH5α and 
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screened using oriM-100_F and oriM-100_R primers, which are located 100 bp 
upstream and downstream of the insertion site. PCR products were visualised on 1% 
agarose and positive clones were sequenced by AWC with the oriM -100 primer set 
to make the plasmid pTkmx_oriM. 
Ligation of Promoters  
Promoters were amplified from gDNA with re designed oligonucleotides containing 
KpnI sites on both forward and reverse primers. These were ligated and cloned into 
either pLUG or pCR2.1 TA cloning vectors, sequenced and cut out using KpnI. 
Ligations with one restriction site 
    
A number of steps were taken to improve the efficiency of these ligations 
 A much higher concentration of promoter DNA was obtained by preparation 
with alkaline lysis instead of using the pellet free plasmid prep kit. 
 During gel extraction as much of the unstained agarose (containing no DNA) 
was removed before the sample was melted in the ADB buffer provided in the 
kit, to improve the DNA yield. 
 The pSHigh plasmid was incubated with KpnI for at least 15 hours and then 
run on 0.8% agarose to visualise the different band size in cut and uncut DNA 
and separate the two.  
 KpnI cut pSHigh was extracted from the agarose gel and then incubated with 
calf intestinal phosphatase (CIP) at 37 oC for 30 minutes; CIP was removed 
from the sample by column purification before ligation. 
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 A pre-ligation heat step involving incubation of plasmid and insert at 65 oC for 
ten minutes to break weak bonds between DNA fragments which may have 
formed dimers.  
 A negative control containing SDW instead of the promoter DNA was 
included. The number of colonies on the negative control plate, containing cut 
plasmid and SDW rather than insertion fragment, gives an indication of the 
efficiency of the ligation.  
2.5 Electroporation of constructs into M. smegmatis 
Reporter constructs were transformed into M. smegmatis mc2155 by electroporation 
with a Biorad gene pulser. Plasmid preparations were desalted by column 
purification and quantified by gel electrophoresis because unclean plasmid 
preparations result in the electroporator arcing. The method for preparation of 
electro-competent M. smegmatis is summarised in appendix 5. Competent cells 
were thawed on ice for 5 minutes before 200 µL of cold 10% glycerol was added to 
each 100 µL aliquot. Between 7 and 10 µL of DNA was added to the cells and 
glycerol, this solution was mixed by gentle pipetting and moved to a cold 
electroporation cuvette. Cells and DNA were then stored on ice for at least 2 hours 
before electroporation. Cuvettes containing cells, DNA and glycerol were pulsed at 
the following settings according to Mycobacteria Protocols 141: 
 Voltage  1250 V 
 Capacitance  25 µF 
 Resistance  1000 Ω 
 Cuvette   2 mm 
Chapter Two: Materials and Methods 
61 
 
After electroporation, cells were allowed to recover overnight in 600 mL LB without 
antibiotics or shaking in eppendorf tubes and then plated on LB kan50 to select for 
plasmid containing clones. M. smegmatis generally takes around 3 days to appear 
on plates, at which point freezer stocks and overnight cultures were made. 
2.5.1 Visualisation of cells 
Cells were visualised under oil immersion for fluorescence using a microscope with a 
FITC (Fluorescein Isothiocyanate) filter. Around 500 µL of cells were removed from 
overnight cultures and washed with equal amounts of 1 x PBS. Cells were then spun 
down for 30 seconds at 12,000 rpm and 400 µL of supernatant removed before re-
suspension. Around 10µL of this concentrated cell solution was used to make slides 
without staining. 
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2.6 Stress Condition Assays 
2.6.1 Oxygen Starvation  
2.6.1.1 Oxygen Starvation Assay with low Copy number constructs 
A method for growing M. smegmatis in oxygen starved conditions has been 
previously described 62.  
For oxygen starvation, HdeB minimal media was made from a stock of metal salts, 
100x nitrates (N), Glycerol and 100x phosphates. 15 mL overnight cultures were 
incubated with agitation of M. smegmatis containing three different plasmid 
constructs: 
 pOT71 (negative control plasmid containing no promoter) 
 pOT71_Rv0440 (positive control promoter containing constitutively expressed 
hsp60 promoter)  
 pOT71_Rv2031 (oxygen sensitive hspX promoter) 
Overnight cultures were diluted to an OD600 of 1.0 in 50 mL HdeB minimal media 
with Kan50 and grown in 250 ml flasks with airtight rubber seals 
53. Triplicate cultures 
were grown at 37 oC with shaking and 1 mL samples of the culture were removed 
periodically with a syringe to avoid oxygen being let into the flasks. These samples 
were measured for OD600 using a spectrophotometer and fluorescence using a 
Wallac envision plate reader with excitation and emission set at 488 nm and 509 nm 
respectively. 
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2.6.1.2 Optimised Oxygen Starvation Assay 
Smaller 15 mL flasks were used with 13 mL of cells and media using up more of the 
total volume. A number of identical flasks were set up so that different cultures could 
be used to measure OD and F at different time points, without letting air in. Cells in 
this assay were grown in rich media instead of HdeB and a final concentration of 1.5 
µg/µL of methylene blue was added to a fourth tube. 
The loss of blue colour in these flasks over 4 days indicated that the level of oxygen 
was being depleted. In addition, the newly made high copy number plasmid pSHigh 
was used. 
2.6.2 High throughput stress conditions 
Overnight cultures of each reporter construct were grown and then diluted to an 
OD600 of 0.2. 50 µL of cells were added to equal volumes of media in a 96 wp, giving 
a final cell turbidity of OD600 0.1. The 96 wps were set up with a gradient of each 
stress condition as summarised in figure 2.1 and table 2.3, each plate containing 
different reporter construct. 
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Figure 2.1: 96 wp set up for stress condition assays. Each promoter construct was 
tested for changes in expression in response to a range of stress factors, displayed in table 
2.3.  SDW and media in the outside wells prevented evaporation and provided a media 
control to establish contamination and background fluorescence.  
 
Stress Final Concentration 
 
Media 
 0% 25% 50% 75% 100%  
Chelators (mM): HdeB 
EDTA 0 0.25 0.5 0.75 1 
EGTA 0 0.25 0.5 0.75 1 
EDDA 0 0.25 0.5 0.75 1 
Antibiotics (µM) LB 
SM 0 0.19 0.39 0.78 1.56 
TC 0 0.1 0.2 0.35 0.75 
RIF 0 0.39 0.78 1.56 3.125 
INH 0 3.125 6.25 12.5 25 
Nutrient Starvation (mLs see appendix 7) HdeB 
Carbon 6 8 12 16 20 
Nitrogen 0.1 2.5 5 7.5 10 
Phosphate 0.1 2.5 5 7.5 10 
Others (%) LB 
EtOH  0 2 3 4 5 
SDS 0 0.02 0.03 0.04 0.05 
  Table 2.3: Stress Conditions. 
A
B
C
D
E
F
G
H 
 1     2     3     4      5     6     7    8     9    10   11   12 SDW 
Media 
0% 
25% 
50% 
75% 
100% 
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2.6.2.1 Nutrient starvation 
15mL overnight cultures of M. smegmatis containing the three TCS controlled 
promoters (phoA, hspX and MtrA) as well as the negative control pSHigh construct 
were grown at 37oC with agitation in HdeB minimal media. These were then diluted 
to an OD600 of 0.1 in a range of 5 different media starvation conditions (0%, 25%, 
50%, 75% and 100% of each nutrient) and transferred to a 96 wp, sealed and 
incubated at 37 oC with agitation for 48 hours. Plates were then removed and read 
for OD and F. A typical 96 wp set up is displayed in figure 2.2. Column 1 of the 96 
wp was filled with SDW to prevent evaporation in other wells and column 12 was 
used for media controls.  
LB was used to grow 15 mL overnight starter cultures, with the exception of the 
phosphate starvation and chelator experiments for which HdeB minimal media was 
used. These were then diluted to an OD600 of 0.2, transferred to 96 wps, sealed and 
incubated with agitation at 37 oC for 48 hours.  
2.6.2.2 Antibiotic stress   
Sub-inhibitory concentrations of 4 antibiotics were tested in this manner namely, RIF, 
INH, SM and tetracycline. The concentration of each antibiotic ranged from half the 
minimum inhibitory concentration (MIC) of each drug in M. smegmatis so that the 
antibiotics would not inhibit growth of the cells in the assay. Table 2.5 indicates final 
concentrations in LB used in this experiment for each antibiotic.  
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2.6.2.3 Chelators 
A number of commercially available chelators from Sigma Aldrich were used in this 
experiment to starve the media of cations; EDTA (Ethylene Diamine Tetraacetic 
Acid), EGTA (Ethylene Glycol Tetraacetic Acid) and EDDA (Ethylene Diamine-N,N'-
Diacetic Acid ) all of which quench media of metal ions. Up to 1 mM of each chelator 
was added to the media in a 96 wp before cells were added. For final concentrations 
used see table 2.3.  
2.6.2.4 Additional Stressors 
Cells were grown to mid exponential phase in LB and then transferred to three 96 
wps where they incubated for half an hour at 4 oC, 37 oC and 45 oC without shaking. 
Plates were then returned to 37oC for half an hour before being read for OD and F. 
Other stress conditions include low levels of SDS (0 – 0.05 %) and ethanol (0-5 %) in 
the LB. 
2.6.3 Validation of Expression Conditions 
Initial findings from the 96 wp assays were repeated with an increased culture 
volume of 50 mL in 250 mL flasks. Triplicate overnight cultures were inoculated and 
diluted in the same way, then incubated with agitation at 37oC for 48 hours before 
OD and F were measured.  
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2.7 Screening For TCS Inhibitors 
2.7.1 Screening Compound Libraries 
Overnight cultures of M. smegmatis containing pShigh_mtrA were grown in 15mL 
rich media with agitation and then diluted to an OD600 of 0.2. An appropriate number 
of 96 wps for each library were dispensed with 50 µL of rich media supplemented 
with Kan50, 0.1 % Tween80 and D-arabinose100 in each well excluding one column of 
SDW to prevent evaporation, as shown in figure 2.6. Using a CyBio liquid handler, 1 
µL of each compound, from a 1 mM stock dissolved in DMSO, was dispensed to 50 
µL of media giving a final concentration of 20 µM of each compound in a final volume 
of 100 µL, after the addition of cells. Diluted cells were aliquotted to each well giving 
an optical density of 0.1 at 600 nm. Controls were added to column 12 including cells 
in rich media with and without DMSO as well as two antibiotic controls usually 
rifampin and capreomycin to show background media fluorescence.  
 
 
 
  
 
 
 
 
 
Figure 2.2: 96 well plate set up for compound library screening. Compounds were 
transferred by a liquid handler from stock solutions to 96 wps. Every well represents a 
different compound, except for the outside wells which contain water, on the left and controls 
on the right.  
A
B
C
D
E
F
G
H 
 1     2     3     4      5     6     7    8     9    10   11   12 SDW 
Cells 
Cells + DMSO 
Antibiotic control 
Compound library 
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Plates were then sealed with plate seals and parafilm and wrapped in gladwrap 
before incubation at 37oC with shaking for 96 hours. Plates were read by a Wallac 
Envision plate reader for OD580 and F (excitation 488 nm and emission 509 nm).   
The phoA promoter driven expression was also tested in a similar way except that 
minimal media was used, supplemented with Kan50 and 0.5 mM EDTA. For these 
plates an additional control of promoterless pShigh was added, instead of having 4 
antibiotic controls. 
2.7.2 Palmitoleic and Oleic Acid Serial Dilutions 
Three 2 x dilutions of each of the fatty acids and a solvent control of ethanol were set 
up in rich media starting from a final concentration of 50 µM. An ethanol solvent 
control was included and these values are shown in the results as 0 µM of each type 
of fatty acid. Cells with an initial OD600 of 0.1 were added to this media, including 
strains containing the plasmids pSHigh, pSHigh_mtrA and pSHigh_hsp60. These 
were incubated and measured for F and OD as described in HTP screen.   
 
 
 
 
Chapter Three: Optimisation of a GFP reporter plasmid 
69 
 
 
 
 
CHAPTER THREE:  
Construction of a GFP 
reporter plasmid 
 
 
 
 
 
 
 
Chapter Three: Optimisation of a GFP reporter plasmid 
70 
 
3.1 Introduction 
In order to screen for potential TCS inhibitors, this study required a method of 
determining the level of TCS controlled gene expression under different stress 
conditions, which could be modified to a 96 wp format for high throughput screening. 
The green fluorescent protein has been used for over a decade, as a reporter of 
gene expression 133 in a number of organisms including mycobacteria 134. By 
inserting the promoter sequence of a gene of interest in front of gfp on a plasmid, the 
amount of protein expressed under the control of this promoter will be indicative of 
promoter activation, which can be measured by the fluorescence intensity. 
 Since its isolation from A. victoria, GFP has been engineered to suit a number of 
applications across many fields in biology. A number of enhanced variants, known as 
eGFPs, were developed by Cormack et al in order to increase the signal strength 
and stability of the protein 136. Taking a rational engineering approach, they used site 
directed mutagenesis to vary the 20 amino acids surrounding the central 
chromophore and screened for improved signal strength with fluorescence activated 
cell sorting (FACS). The result was GFPmut2, with a 100 fold  increase in 
fluorescence compared with wild type GFP and a red shift in its natural excitation 
and emission spectra from 395 nm to 488 nm, making it more compatible with 
techniques such as FACS and FITC filtration 136.  
In this study GFPmut2 was chosen as a reporter over other methods, such as xylE 
expression, for a number of reasons. Firstly, as GFP is activated by light of a specific 
wavelength there is no substrate required, which can interfere with other cellular 
processes. Secondly, the intensity of a fluorescent signal can be easily measured 
using a FITC filter under a microscope, and quantified in a 96 wp fluorescence 
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reader. Finally, this reporter is well established as a measure of gene expression in 
mycobacteria 134.  
A number of mycobacterial promoters are constitutively expressed and induce 
protein formation all the time; these are sometimes known as “housekeeping” genes. 
GFP expression under the control of the constitutively expressed promoter from the 
hsp60 gene, for example, gives off relatively high levels of fluorescence. Many 
others, such as the TCS-controlled genes which were selected in this study, induce 
GFP expression under certain conditions, but never at the same level as the hsp60 
promoter. In order to monitor relatively small changes in gene expression as a result 
of stress conditions, a very sensitive reporter system was required. The GFPmut2 
variant has been well adapted to measure bacterial gene expression; however 
another means of improving signal strength is to increase the number of plasmids 
per cell.  
Bourn et al showed that a modification to the pAL5000 mycobacterial origin of 
replication on a plasmid resulted in a seven fold increase in plasmid copy number 
per cell  138. In this chapter, the development of the new plasmid pSHigh containing 
gfpmut2 and the modified pAL5000, will be described. Its relative fluorescence will 
be established and compared with that of low copy number plasmids containing the 
same GFPmut2 under the control of the hsp60 promoter. Having demonstrated an 
increase in signal strength, the phoA, hspX and mtrA promoters from M. smegmatis 
were amplified and used to replace the hsp60 promoter for further analysis of the 
TCS they control.  
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3.2 Results      
Construction of the reporter plasmid pSHigh involved a number of steps 142. An 
overview of the process in shown in figure 3.1 
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3.2.1 Amplification of gfpmut2 and oriM hi 
Figure 3.1. Construction of pSHigh, an optimised 
GFP reporter plasmid. The gfp gene, along with its 
ribosomal binding site (RBS), was amplified from 
pOT11 using GFP_RBS_F  and GFP_R  primers. 
This fragment replaced the xylE of pTKmx using its 
KpnI and SphI restriction sites to make pTKmx_GFP. 
The modified oriM of pHS201 was amplified with 
oriM_F and oriM_R primers and this modified origin of 
replication replaced the oriM region of pTKmx_GFP 
using the surrounding NheI sites. 
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3.2.1 Amplification of GFPmut2 and OriM by PCR 
The optimised reporter plasmid pSHigh was developed by cloning a new origin of 
replication oriM high and gfpmut2 into a mycobacterial plasmid pTKmx created by 
Kenney and Churchwood 137. Figure 3.2 shows the PCR products of the amplification 
of gfpmut2 from pOT11 and oriM high from pHS201 on 1 % agarose. A gradient 
PCR showed that the optimal annealing temperature for cloning the oriM high 
fragment was 63 oC, as shown in figure 3.2 (a).  
     
 
Figure 3.2: Visualisation of gfpmut2 and oriM high amplified PCR products. A) gfpmut2 
along with its RBS was amplified by PCR using pOT11 as a template, giving an 800bp 
product on the agarose gel. B) OriM was amplified effectively from pHS201 using an 
annealing temperature of 63oC, giving a 2500 bp product shown in the sixth lane. 
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3.2.2 Switching xylE and pAL5000 with GFPmut2 and oriM high in pTKmx 
The mycobacterial plasmid pTKmx was used as the backbone for pSHigh. Kenney et 
al used this plasmid to monitor promoter activity with the xylE reporter system 137, 
which we replaced with gfpmut2. OriM high was substituted for pAL5000 to increase 
the copy number of the plasmid per cell. Figure 3.3 illustrates how this plasmid was 
cut with restriction enzymes KpnI and SphI to remove xylE and NheI to remove 
pAL5000. The white boxes on the gel show the bands which were removed and gel 
purified, pTKmx – xylE and pTKmx –pAL5000.    
                                                                                                               
 
         
    
 
 
3.2.3 Comparing the fluorescence of high and low copy number plasmids in M.  
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Figure 3.3: Removal of xylE and pAL5000 from pTKmx by restriction enzyme 
digest. KpnI and SphI were used to remove the xylE fragment and NheI to remove 
pAL5000 from pTKmx giving band sizes corresponding to the size of these fragments in 
relation to the plasmid These fragments were then replaced with gfpmut2 and oriM high 
to make pSHigh 
1 kb 
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3.2.3 Comparing the Fluorescence of high and low copy number plasmids in 
M. smegmatis 
The fluorescence of overnight cultures of M. smegmatis containing high and low 
copy number plasmids were compared on a single cell basis, using a microscope 
with a FITC filter, and on a population basis, using a  96 wp fluorescence reader. In 
figure 3.4 M. smegmatis cells containing different plasmids are displayed along with 
a map of essential elements contained on each plasmid. The high copy number 
plasmids, pHS201 and pSHigh_hsp60 display a much higher level of fluorescence 
compared with pOT62, with exactly the same GFPmut2 and RBS sequence as 
pSHigh_Hsp60. Images of the pHIGH100 and pSHigh plasmids show little 
fluorescence indicating that GFP expression is a result of the hsp60 promoter 
induction. The pSHigh reporter constructs were used over the pHS201 and 
pHIGH100 plasmids because they contained a unique cloning site directly upstream 
of the gfp gene and the trp terminator site from pTKmx. The cloning site allowed for 
the insertion of other promoters upstream of the gfp gene. It was hoped that the 
terminator site would reduce any background fluorescence from the gfp gene. 
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           pHIGH100 
           pHS201 
           pSHigh 
            pSHigh_Hsp60 
             pTKmx_GFP 
           pTKmx 
             pOT62 
 
         
 
 
 
 
PHsp60 gfp 
OriM (high 
copy number) 
Figure 3.4: Visualisation of reporter constructs in M. smegmatis.  
Cells containing plasmids used in this study were visualised for gfp 
expression using a blue light with a FITC filter (475 nm) (column A), 
white light (column B) and both (column C). Cells containing the high 
copy number origin of replication shown on plasmids maps in blue 
were significantly more fluorescence than those with the original 
pAL5000 origin. Low level fluorescence of the promoterless plasmids 
indicates no significant leakage of GFP expression.  Scale bar shown 
in white on all photographs represents 2 µm. 
 
A B C 
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To explore whether the dynamic range of GFP expression was increased in a 
population of transformed cells we measured the fluorescence in relation to OD of 
the cultures. As figure 3.5 shows, the level of fluorescence in the high copy number 
plasmids pHS201 and pSHigh_Hsp60 is significantly higher than that of pOT62. The 
low level of fluorescence from pTKmx indicates that a small amount of fluorescence 
is picked up from cells without any GFP expression. 
 
Figure 3.5: Relative Fluorescence of Reporter plasmids in M. smegmatis. High copy 
number plasmids pHS201 and pShigh_hsp60 display significantly higher levels of 
fluorescence than their promoterless counter-parts pHIGH100 and pSHigh. pOT62 
containing the same promoter, RBS and gfp sequence as pSHigh_Hsp60 gives off less 
fluorescence, presumably as a result of the number of plasmids per cell. Error bars indicate 
the standard deviation between triplicate cultures. 
 
In order to calculate the level of GFP expression the hsp60 promoter conferred to a 
cell, the readings were normalised to show the fluorescence in relation to OD minus 
the background fluorescence given off by normal cells, as indicated by pTKmx.  
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Table 3.1 displays the calculated normalised fluorescence and the fold induction as a 
result of the hsp60 promoter. 
 
 Normalised 
promoterless gfp 
expression 
Normalised Phsp60 
driven gfp 
expression 
Fold 
induction 
Low copy number 
pOT62, pTkmx_GFP 
 
245783.2 
 
731867.7 
 
3 
High Copy number  
pHS201, pHIGH100  
 
398280.5 
 
2500922 
 
6.3 
High Copy number 
pSHigh_Hsp60, pSHigh 
 
241118.2 
 
2412564 
 
10.0 
Table 3.1: Normalised fluorescence of high and low copy number plasmids. 
 
3.3 Inserting TCS controlled gene promoters into pSHigh 
A literature search for TCS controlled genes in mycobacteria revealed a number of 
candidates. These were narrowed down to three M. smegmatis genes with non 
coding sequences upstream which could be amplified from genomic DNA and cloned 
into the pSHigh plasmid. A number of M. tuberculosis promoters were also amplified 
for future work in M. bovis BCG.  Table 3.2 shows known TCS controlled genes from 
M. smegmatis and M. tuberculosis and what conditions are proposed for their 
induction.  
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Gene name TCS Conditions of 
expression 
Function if known 
Current Work     
MSMEG_3932 
(hspX) 
DevS/DevR Oxygen starvation, 
nitric oxide stress 
Induction of dormancy regulon 
62, 63 
MSMEG_1872* 
(mtrA) 
MtrB/ MtrA Possibly iron 
starvation 
Macrophage infection 101 
MSMEG_1012 
(phoA) 
SenX3/ 
RegX3 
Phosphate starvation Phosphate transport and 
metabolism 108 
Rv0440 
(GroEL2/Hsp60) 
- Constitutively 
expressed positive 
control 
 
Future Work in Mycobacterium tuberculosis 
Rv2031 (hspX) DevS/DevR Oxygen starvation, 
nitric oxide stress, 
SDS  
Induction of dormancy regulon 
143 
Rv1221 (sigE) MprB/MprA heat shock, tissue 
specific ligands?  
Host inflammatory response 89, 
144 intracellular persistence 145 
Rv2396  PhoP/PhoR Low magnesium and 
other cations 89 
Complex lipid biosynthesis 87, 
146 
Rv1033 (tcrR)* TrcR/TcrS unknown  
Rv0903 (prrA)* PrrB/ PrrA unknown Early intracellular growth86, 147 
Rv3246 (mtrA)* MtrB/ MtrA Possibily iron 
starvation 71 
Intramacrophage replication 148 
Table 3.2. Two Component system controlled genes cloned for this study and future 
work. * indicates autoregulated response regulators of the TCS. 
 
Three selected M. smegmatis genes, hspx, mtrA and phoA, were used in this study. 
The gene organisation and function of surrounding genes is described in figure 3.6. 
In order to use these genes in a promoter reporter plasmid it was important that a 
defined non-coding region directly upstream could be demonstrated for each. 
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Gene Name Function 
MSMEG_1010 Transcriptional regulator, TetR family 
MSMEG_1011 Short chain dehydrogenase 
MSMEG_1012 phoA: Alkaline phosphatase 
MSMEG_1013 Hypothetical protein 
MSMEG_1014 DNA polymerase IV 
MSMEG_1015 Transcriptional regulator, TetR family 
MSMEG_1016 Secreted protein 
 
 
 
Gene Name Function 
MSMEG_1873 Thymidylate kinase 
MSMEG_1874 mtrA: Two component system response regulator 
MSMEG_1875 mtrB: Two component system histidine kinase, OmpR family 
MSMEG_1876 Lipoprotein 
MSMEG_177 Hypothetical protein 
 
 
 
 
Gene Name Function 
MSMEG_3926 to MSMEG_3931 Subunits of hydrogenase enzyme 
MSMEG_3932 hspX homologue: 14kD antigen 
MSMEG_3933 Phophophenolpyruvate synthase 
MSMEG_3934, 3935 and 3937 Hypothetical protein 
MSMEG_3936, 3938, 3939, 3940 Universal stress proteins 
MSMEG_3941  GAF family protein 
MSMEG_3942 Hypothetical protein 
MSMEG_3943 Hypothetical protein 
MSMEG_3944 DevR: Two component system response regulator DevR 
 
 
Figure 3.6 Gene organisation and function of selected TCS controlled genes.  All 
selected genes possess non-coding regions directly upstream of their start codon. The 
genes surrounding these are named and labelled in the order that they appear from left to 
right. This information was downloaded from the website www.genome.jp.  
 
hspX 
mtrA 
phoA 
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3.3.1 Promoter Amplification by PCR from Genomic DNA 
Promoter sequences upstream of each gene were amplified from M. tuberculosis 
and M. smegmatis genomic DNA to give fragments of approximately 600 bp. Figure 
3.7 shows the 1 % agarose gels of the promoters amplified by PCR. 
A. 
 
B. 
                                              
Figure 3.7: Promoters amplified from M. smegmatis and M. tuberculosis gDNA.  A) 
displays five TCS controlled gene promoters of around 600bp in size, as well as the 
constitutively expressed hsp60 promoter amplified from M. tuberculosis genomic DNA. In B) 
three bands represent M. smegmatis promoters from selected TCS controlled genes. 
600bp 
R
v3
24
6
 (
m
tr
A
) 
R
v0
90
3
 (
p
p
rA
) 
R
v0
44
0
 (
h
sp
6
0
) 
R
v1
22
1
 (
si
g
E)
 
R
v2
03
1
 (
h
sp
X
) 
R
v1
03
3
 (
tc
rR
) 
600bp 
M
SM
_3
93
2
 (
H
sp
X
) 
 
M
SM
_1
01
2
  (
p
h
o
A
) 
M
SM
_1
87
4
 (
M
tr
A
) 
R
v0
4
40
_H
sp
60
 
Chapter Three: Optimisation of a GFP reporter plasmid 
83 
 
3.3.2 Ligation of promoters into pSHigh 
In order to improve the efficiency of the ligation of promoters into the reporter 
plasmid, the KpnI cut pSHigh was gel extracted to reduce the amount of uncut 
plasmid DNA during each ligation reaction.  Figure 3.8 shows the pSHigh plasmid in 
its uncut state and after digestion with KpnI, the band removed from the gel is 
highlighted by a white box. 
 
Figure 3.8: KpnI cut and uncut pSHigh plasmid. The sixth lane shows coiled formations 
of the pSHigh plasmid in its uncut state. The three following lanes display pSHigh after being 
cut with KpnI. The cut plasmid DNA, shown in a box, was removed by gel extraction.    
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3.4 Discussion 
3.4.1 Optimisation of the reporter plasmid 
The principal aim of this work was to generate a cell based screen for TCS inhibitors. 
This required a highly sensitive reporter system which could be manipulated to 
identify small changes in gene expression as a result of TCS-specific conditions. The 
results of section 3.2.3 clearly show that pSHigh_Hsp60 is a highly fluorescent 
reporter construct and this is a result of the change in the origin of replication of the 
plasmid from pAL5000 to oriM high. Only a limited amount of background 
fluorescence is produced from the promoterless pSHigh plasmid, when compared 
with the pTKmx strain, indicating the plasmid does not express the protein 
independently of an adjacent promoter sequence upstream of gfpmut2. The plasmid 
also contains a kanamycin resistance cassette for antibiotic selection and an E. coli 
origin of replication oriE. This pSHigh_hsp60 plasmid was used as a constitutively 
expressed control in this study, and has also been used for screening compound 
libraries against mycobacteria.  The plasmid displays high levels of measurable 
fluorescence which can also indicate cell viability when OD readings cannot be used 
due to interference by coloured compounds.  
 The authors who created the pHS201 vector describe a significant increase in 
plasmid copy number from around five per cell to between 32 and 64 copies of the 
same plasmid 138. The advantage of the pSHigh plasmid over the pHS201 vector is 
its unique KpnI restriction site, directly upstream from the gfpmut2 gene, allowing 
other promoters to be cloned in frame with the ribosomal binding site to monitor gene 
expression. In addition the trpA terminator sequence from pTKmx, located 
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downstream of this cloning site lead to a lower level of background fluorescence 
from the promoterless plasmid control.  
When using a reporter to monitor gene expression, a number of assumptions are 
made. Firstly, any changes in fluorescence demonstrated are a result of activation or 
repression of a particular promoter. Therefore any post translational modification to 
proteins in a cell which are not directly affected by activation or repression of that 
promoter will not be demonstrated by the reporter system. Fortunately, the three 
promoters selected for this work have been previously studied and RR promoter 
binding sites have been demonstrated. This type of method may not be suitable for 
other target genes if their protein concentration or activity within the cell is controlled 
by some mechanism other than promoter activation. 
One also assumes that the number of plasmids per cell remains relatively consistent 
between cultures. Measuring the fluorescence of a cell indicates the amount of 
protein expressed therein and is dependent on the number of plasmids present. We 
calculate the relative fluorescence (rF) as a measure of fluorescence divided by the 
OD of a culture of cells, to generate a number which is relative to the number of cells 
present, but we cannot account for the number of plasmids in each cell and assume 
that this remains relatively constant.    
Another concern with this methodology is the effect a reporter may have on cellular 
function. The use of GFPmut2 has been established in a number of species and no 
significant adverse reactions to the cell have been noted. It is shown in figure 3.3 
that cells expressing GFP appear normal and seem as healthy as those not 
expressing the protein. The benefits of this reporter over substrate based systems 
such as xylE are clear in this regard, although some work has indicated that 
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exposure to certain wavelengths of light can cause photo bleaching of the protein, 
reducing its fluorescence 149.  
3.4.2 Selection of TCS promoters 
As not all TCS controlled genes have had their promoters sequences published, it 
was important that a substantial intergenic region could be identified directly 
upstream of selected genes for RR binding. It is known that certain genes are 
controlled as part of an operon rather than direct binding at each one’s promoter site, 
which meant some of the TCSs could not be included. Figure 3.5 indicates that 
genes selected for this study all qualify in this regard. We included genes such as 
HspX and PhoA, whose promoter binding sites are known 108, 150. MtrA is an auto-
regulated gene, in that induction of this TCS confers expression of its own response 
regulator 89.  
The importance of these TCS in terms of dormancy (hspX), phosphate starvation 
(phoA) and survival in the macrophage (mtrA) has been discussed in some detail in 
the opening chapter. The conditions for hspX and phoA induction have been 
demonstrated in previous work, but the control of the mtrA gene is something of a 
mystery despite its proposed essentiality in M. tuberculosis. The idea of using the 
hspX and mtrA promoters as drug targets came from the fact that their M. 
tuberculosis homologues are involved in signal transduction mechanisms which are 
vital to mycobacterial survival and latency. PhoA, on the other hand is absent in M. 
tuberculosis. Its established induction during phosphate starvation in M. smegmatis 
and E. coli, however, make it an attractive target in terms of screening for a broad 
class of TCS inhibitors which affect a conserved part of the phosphorylation transfer 
and may inhibit a number of TCS mycobacteria and other species of bacteria.   
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4.1 Introduction 
The basis of TCS signal transduction relies on the recognition of some 
environmental or internal change in conditions by the sensor kinase, leading to a 
congruent change in gene expression. We aimed to imitate in vivo stress conditions 
with a number of in vitro stressors in order to determine any changes in the 
expression of the TCS regulated genes.  
Our assumption is that during macrophage infection and granuloma-induced 
dormancy the AFB is subject to considerable environmental stress; from the host 
immune response, nutrient starvation and a limited supply of oxygen. Although it is 
difficult to accurately reproduce the whole spectrum of these conditions in vitro, 
studies of the granuloma have suggested a number of states which can be 
simulated. Importantly, AFB are often found in locations within the granuloma which 
exhibit low oxygen tension in relevant animal models of the disease 116. Despite the 
fact that their prominent site of infection is the lung, the AFB survive for extended 
periods of time in a relatively hypoxic environment.  
Another key feature of the granuloma is the fact that it is made up of and constantly 
surrounded by host immune cells. These cells secrete chemokines, cytokines and 
nitric oxide products intended to rid the host of pathogenic bacilli. The host response 
mounted to counter a mycobacterial infection will differ from person to person, 
however, some of these hostile host responses can be imitated  in vitro.. Heat and 
cold shock, changes in pH, addition of low levels of SDS, ethanol or antibiotics to 
media at low levels are predicted to activate cellular stress responses which may 
induce the expression of TCS controlled genes involved in macrophage or 
granuloma survival. 
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Finally, the use of HdeB minimal media can effectively control the level of particular 
nutrients available to cells. This media can be modified to alter the concentration of 
available carbon, nitrogen and phosphate. In addition to the direct removal of 
elements from the media, chelators can be used to remove cations such as calcium, 
magnesium and iron.  
By measuring the effect of these stress conditions on TCS controlled gene 
expression we can elucidate the possible activators of these systems. As a proof of 
principal, hspX expression was measured during oxygen starvation, a known 
activator of the DevS/ DevR TCS dormancy response. This was followed by a 
number of other stress conditions described in the materials and methods section, 
which were applied to all three TCS controlled promoters phoA, mtrA and hspX.   
The remainder of this chapter will describe the significant findings on the influence of 
stress condition on TCS regulated gene expression. 
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4.2 Results 
Cells containing GFP reporter constructs were exposed to a number of stress 
conditions throughout this study. For simplicity, only those with a reproducible 
outcome will be described here.  
 
4.2.1 Expression of the DevS/DevR dependent hspX promoter  
The DevS/DevR TCS is known to promote the expression of hspX under conditions 
of oxygen starvation and nitric oxide stress 143, 151. Other authors have shown an 
increase in hspX mRNA during growth in media with 5% ethanol and to a lesser 
extent hydrogen peroxide 152.  
In order to demonstrate that the hspX reporter plasmid was oxygen dependent two 
oxygen starvation assays were carried out. The first was using a low copy number 
pOT71 plasmid and a method described in a previous publication 62, shown in figure 
4.1. After 35 hours, the hspX-driven expression increased to a level that was higher 
than that of the promoterless pSHigh plasmid. The positive control, hsp60 driven 
gene expression, is generally much higher and is variable over different time points. 
 
 
 
 
 
Chapter Four: Conditions of TCS controlled Gene Expression 
91 
 
 
 
 
Figure 4.1: HspX expression during oxygen starvation using low copy number 
plasmids. In figure A) the OD is shown over 35 hours of growth. When cultures reached 
stationary phase, at around 14 hours, cells were measured for fluorescence as shown in 
B).Only at 35 hours is there an increase in hspX expression. Error bars indicate the standard 
deviation between triplicate cultures.   
A 
B 
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Another means of oxygen starvation was achieved based on a number of other 
methods used in current literature 56, 153.  We reasoned that there were a number of 
problems with the original assay and made appropriate alterations to our method. 
Smaller flasks with a larger volume of media were used to reduce the amount of air 
in each culture to start with. Another alteration to the original method was the use of 
rich rather than minimal media. We argued that cells are less likely to reach 
stationary phase as a result of some limiting factor other than oxygen, if they are 
living in rich media.   
Using an optimised oxygen starvation method and the improved high copy number 
pSHigh plasmid (amongst other changes to this method described in section 2.7), a 
higher level of fluorescence was produced (figure 4.2). A number of changes were 
made to this assay to increase the stringency of oxygen starvation and observe a 
higher level of GFP expression under the control of the hspX promoter after 4 days. 
Contrasting these results with figure 4.1 indicates that a combination of the method 
of oxygen starvation and choice of plasmid constructs results in higher hspX 
promoter induction after 4 days. 
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Figure 4.2: HspX expression using an optimised oxygen starvation method and high 
copy number plasmids. An increase in hspX expression is observed after 4 days of growth 
without shaking. Changes in hsp60 expression do not appear to change significantly with 
time. Error bars indicate the standard deviation between triplicate cultures. 
 
 
 
4.2.2 Expression of the SenX3/ RegX3 dependent phoA promoter  
The phoA gene of M. smegmatis is induced by the SenX3/ RegX3 TCS under 
conditions of phosphate starvation 108. It was demonstrated that both phosphate and 
magnesium concentration influence the expression of the gene in our in vitro model. 
Using HdeB minimal media, the level of phosphate in culture media was altered to 
bring about stationary phase growth in a population of cells as a result of phosphate 
starvation. The source of phosphate in HdeB minimal media is a solution of K2HPO4 
and NaH2PO4 added at 10 mM and 7 mM respectively (for more details see 
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appendix 7).   As figure 4.3 indicates, lower levels of phosphate in the media bring 
about an increase in phoA promoter activation compared with the promoterless 
pSHigh plasmid grown in the same condition.   
 
Figure 4.3: The effect of phosphate starvation on phoA expression. The amount of 100 
x phosphate solution added to HdeB minimal media was altered to adjust the percentage of 
phosphates available to cells whereby 100 % is equivalent to that of minimal media. Using 
media with only 20 % of the required phosphate leads to a change in phoA expression. Error 
bars indicate the standard deviation between triplicate cultures.   
Figure 4.4 demonstrates that a range of EDTA concentrations also had an effect on 
phoA expression. A final concentration of 0.5 mM EDTA added to minimal media 
seems to induce the expression of this gene. It was observed that a final 
concentration of more than 1.0 mM EDTA resulted in a slow growth rate of cells, 
increasing the variation of the data collected, which is perhaps why fluorescence 
does not increase with concentration.  
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Figure 4.4: The effect of magnesium starvation on phoA expression.  At a final 
concentration of 0.5 mM EDTA, the fluorescence produced by the phoA promoter is 
increased compared with the promoterless pSHigh plasmid. Error bars indicate the standard 
deviation between triplicate cultures.   
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4.2.3 Expression of the MtrB/MtrA dependent mtrA promoter  
The GFP expression resulting from the mtrA promoter activation was higher than any 
other TCS used in this study. A higher level of fluorescence was observed in rich 
media and the mtrA promoter expressed GFP remained relatively consistent across 
all the degrees of stress that it was exposed to, with the exception of EDTA. In rich 
media, a control plasmid containing the reverse orientation of the promoter shows 
little fluorescence compared with the same sequence in the correct orientation with 
relation to gfp. As shown below in figure 4.5. 
 
 
Figure 4.5: The expression of mtrA in rich media. The correct orientation of the promoter 
in relation the gfp on the reporter plasmid was required to give a high level of expression. 
Error bars indicate the standard deviation between triplicate cultures. 
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There was also a change in fluorescence as a result of increasing EDTA 
concentration. Figure 4.6 indicates that a final concentration of 1 mM EDTA induced 
a higher level of fluorescence than other concentrations. This indicates that the 
addition of EDTA at this concentration has an effect on the mtrA promoter activation, 
possibly due to an effect of changes to the magnesium concentration of the media.  
 
Figure 4.6: The effect of magnesium starvation on mtrA expression. A high level of 
expression is seen at a final concentration of 1 mM EDTA in the HdeB media. Error bars 
indicate the standard deviation between triplicate cultures.   
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4.3 Discussion 
4.3 1 Expression of the DevS/DevR dependent hspX promoter  
The oxygen starvation growth curves gave the highest hspX-induced rF for any 
condition using this promoter construct, especially with the optimised method. As a 
number of variables were changed, including the time allowed for oxygen starvation, 
the copy number of the plasmid, the media used and volume of air in the flask to 
begin with, we cannot specify exactly what caused the improved results. None the 
less, figure 4.2 shows that hspX was induced by oxygen starvation. This provided a 
proof of principle that using a promoter reporter system to monitor gene expression 
of a TCS-controlled gene accurately.  
Surprisingly, other reported activators of expression such as, SDS and ethanol 
stress did not give a reproducible result for this assay. There are a number of 
possible reasons for this, mainly relating to differences in the method used.  The up 
regulation of hspX found by Kendall et al 152 was shown by rtPCR. This method may 
be more effective at recognising small changes in gene expression which are a 
consequence of downstream effects of the stressors. Studies suggests that the 
sensor kinase DevS contains heme binding GAF domains, and these are likely to 
respond to oxygen tension 60. Other authors suggest that carbon monoxide is the 
critical ligand of this sensor kinase 154, 155. The response seen to nitric oxide may 
result from its ability to inhibit respiration rather than direct binding ligand binding 156. 
Similarly, ethanol and SDS may be detrimental to cells in a way that reduces aerobic 
respiration and induces a dormancy response.  
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Another possibility is that these alternate inducers of the hspX gene occur as an 
effect of another stress response, rather than the hypoxia induced dormancy regulon 
151. As mentioned in the introduction, the highest level of cross talk between TCS 
signal transduction mechanisms is the overlap in genes under their control 90. HspX 
may be induced by a number of other signal transduction mechanisms controlled by 
other stressors, at a lower level than that seen during oxygen starvation.        
 One problem involved in this type of assay is the effect stressful conditions have on 
the OD of a cell culture. Adding stressors like ethanol and SDS, even at a low 
concentration will limit the cell growth in a solution. A small difference in 
concentration of a stress inducing agent between wells of a 96 wp will equate to a 
large difference in cell density and a high degree of variability. The only quantifiable 
way of showing a change is to compare the difference in fluorescence between 
pShigh_hspX and pSHigh, with and without that stress condition. Herein lies another 
problem in that any differences in growth rate between the strains used in the 
experiment will mask a significant result. There are several reasons that this may 
occur, such as how long the strain has been stored at -80 oC, the copy number of the 
plasmid (in other words how much of the antibiotic resistance gene is expressed) 
and the burden of expressed protein on a cell.  
A more relative and labour intensive method would have been to use FACS to 
determine fluorescence of each cell rather than an entire large culture, when using 
conditions which impaired growth. However relating this to a HTS assay would be 
near impossible.  
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4.3.2 Expression of the SenX3/ RegX3 dependent phoA promoter  
The activation of the SenX3/RegX3 controlled phoA promoter was demonstrated in 
two conditions; phosphate starvation and magnesium depletion. The former 
condition was anticipated based on f what is known about phoA’s role in phosphate 
metabolism; however the result from adding magnesium chelator EDTA was not. 
There are a number of theories as to why this may be the case, none of which we 
can validate from this experiment alone.  
Firstly, EDTA is a major chelator of magnesium, but it also chelates a number of 
other cations in media including calcium. To conclude that this effect is a direct result 
of magnesium starvation is an over-simplification. One could conclusively show this 
by setting up a minimal media depleted of magnesium and compare and contrast the 
result. 
Another theory is that EDTA may have some effect on the cell wall integrity of the 
mycobacteria, or the phosphate importer/exporter pump system which is affecting 
the expression of this gene in some way. It was suggested by Ryndak et al that phoP 
mutants were unable to survive in EDTA supplemented media as a result of 
detrimental changes in the cell wall caused by this chelator,  which could also 
explain what is happening in this case 157.  
The level of EDTA in media can have an effect on cell density, indicating it presents 
a certain amount of stress on a cell. It could be that this gene is upregulated as a 
more globally controlled stress response by the cell in addition to the SenX3/RegX3 
phosphate specific induction. Another signalling system may well control the 
expression of this gene. Once again, the possibility of overlap in genes expressed by 
isolated signal transduction systems may be worth considering here 90. The PhoP/ 
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PhoR system is thought to be controlled by magnesium concentration and is 
involved in cell wall maintenance, phoA or SenX3/RegX3 could easily be influenced 
by this TCS as well as the PST PIT phosphate transport systems. 
It is also plausible that this TCS is controlled by more than just phosphate starvation 
via multiple ligand binding sites. The RegX3 sensor kinase is not itself membrane 
bound, interacting with a phosphate specific transporter (PST) which senses the 
external phosphate concentration 108 . Presumably, it is the result of a change in this 
transporter which causes dimerization of the sensor kinase and not a direct response 
to a reduction in phosphate acting on the kinase itself. So any other ligand affecting 
this phosphate transporter, the SenX3 sensor kinase or the interaction between the 
two may have downstream effects on the expression of phoA.  A protein 
phosphatase assay using only the isolated HK and RR of SenX3/ RegX3 would be 
one way to show if the histidine kinase responded to magnesium independently of 
the PST.  
4.3.3 Expression of the MtrB/ MtrA dependent mtrA 
The activation of the mtrA promoter was not higher in any of the stress conditions 
than in rich media. Since this gene is thought to be essential to M. tuberculosis 101 , it 
may also be essential to M. smegmatis. By definition an essential gene is one 
required for cell growth; therefore some constitutive expression would be expected in 
rich media.  
Studies have shown that this gene is induced during intra-macrophage growth. Only 
one of the in vitro models of the macrophage or granuloma environment presented 
here induced an effect on mtrA expression; EDTA. Activation of mtrA was generally 
Chapter Four: Conditions of TCS controlled Gene Expression 
102 
 
much lower in minimal media than that observed in rich media. As figure 4.6 shows, 
there is very little fluorescence without the addition of EDTA in minimal media. While 
this data indicates that EDTA-dependent ion depletion may have an effect on mtrA 
activation, this does not conclusively demonstrate that the sensor kinase directly 
responds to magnesium.  
The inducer of this TCS is still unclear 112, 158 but one suggestion is iron starvation 71. 
Rodrigues et al, who profiled iron-responsive gene expression using microarrays, 
saw an increase in the expression of mtrA during iron starvation 71. In the current 
study, however, the use of an iron chelator EDDA did not seem to render any 
increase in mtrA expression. This would be worth exploring, by omitting iron from the 
minimal media rather than using a chelator in case the EDDA concentration used in 
this study was not optimal and did not chelate all the iron in solution. In order to show 
that magnesium or iron is a ligand of the MtrB histidine kinase, further work on the 
crystal structure and binding properties of this protein is required. EDTA was used in 
this assay to deplete free magnesium from the media, but the possibility exists that it 
causes a multitude of effects on cellular morphology independent of specific ion 
starvation. 
The reporter protein GFPmut2 is relatively stable; consequently endpoint readings in 
such an assay will not disclose exactly when the gene is induced.  If mtrA is 
expressed at a particular point of the growth phase our assay picks up the GFP 
expression at the end of the growth assay. Using an unstable variant of GFP, such 
as that developed by Blokpoel et al. 2003, may give a better idea of phase 
dependent expression of this gene 134. 
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Our aim of finding a high level of GFP expression for each TCS controlled promoter 
was fulfilled with rich media for this TCS. Even though EDTA induced a high level of 
expression, its use in high throughput assays was not advantageous as minimal 
media gives a much higher level of variance in a 96 wp format.  
 Another concern was the addition of EDTA to media as this may have a profound 
effect on the action of compounds used in library screens. In the end it was decided 
that rich media could be used for high throughput (HTP) screening because a more 
stable rate of growth could be achieved. Another benefit was that this data could be 
compared with other screens using the hsp60 promoter which were also carried out 
in rich media.  
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5.1 Introduction 
The overall aim of this project was to develop a GFP reporter and optimize 
conditions under which TCS controlled genes were highly expressedto develop an 
assay which identified compounds which inhibit this sort of signal transduction. In 
order to test as many compounds as possible, a high throughput method was 
employed, whereby thousands of compounds could be tested for their effect on the 
expression of these genes. Using a liquid handler, a large number of compounds 
could be added to separate wells of a 96 wp and incubated with M. smegmatis cells 
to observe changes in fluorescence.  In theory a compound affecting any of the 
steps in the phospho transfer from a histidine kinase to response regulator and 
consequential DNA binding could cause a reduction in fluorescence driven by the 
TCS controlled promoter.  
There are numerous benefits of using this whole cell approach to target TCS 
compared with isolated protein methods, as mentioned in the introductory chapter. 
The main advantage is that a compound inhibiting any reaction in the signal 
transduction mechanism may be identified, rather than targeting a single protein. 
Compounds which inhibit another target, resulting in a decrease in cell growth, will 
also display a decrease in fluorescence. By observing the OD of each well we are 
able to identify general cell growth inhibitors and eliminate these from the list of 
positive findings.  
Another important point is the fact that all known TCSi affect the cell membrane in 
addition to any signal transduction inhibitory action. Using this screen, the OD of the 
cell suspension is taken into account so compounds which act on the cell in some 
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other fashion, such as a detrimental effects on membrane integrity, will not be picked 
up. 
A number of compound libraries available were tested for an effect on the activation 
of the mtrA promoter, including the LOPAC, Spectrum Collection, NIH diversity 
collections and a library of natural compounds isolated from marine organisms which 
will be known as the NIWA collection. MtrB/ MtrA was selected as it showed high 
levels of expression in rich media without the addition of growth inhibitors such as 
EDTA. This meant that we could expect a uniform growth rate and limited interaction 
between compounds and the chelator. One compound library, the LOPAC library, 
was screened against phoA driven expression, but as the results will show, the 
difference between phoA-induced expression and promoterless expression of GFP 
from pSHigh was too variable in this high throughput format to discern differences in 
fluorescence as a result of a compound interaction with the SenX3/ RegX3 TCS. The 
oxygen starvation assay, which was described in chapter 4, did not translate well to 
a 96 wp format. It was not possible to obtain a high level of fluorescence from the 
hspX promoter that was uniform across the plate by increasing the volume of liquid 
in each well and creating an airtight seal.  
In order to ascertain that there was no inhibition from the solvent used to dissolve the 
compound libraries, a negative control was included containing the same volume of 
DMSO added to two wells of each plate instead of a compound. As a positive 
control, to show the effect of compounds which inhibit cell growth outright, antibiotics 
were added to two wells of each plate.     
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5.2 Results 
5.2.1 Compound Library Screens against mtrA expression 
5.2.1.1 Spectrum Library against mtrA expression  
Fluorescence (F) and OD data were plotted on a scatter graph to reveal any 
changes in F without a change in OD, shown in figure 5.1. If a compound inhibits 
growth of the cells it will also lead to a decrease in F due to the reduction in cell 
number per well so we were looking for compounds which act on F alone. For each 
library, the median Fand OD readings are shown as the X and Y axes respectively 
so that as a rough guide compounds in the top left quarter of each graph could be 
considered to have an effect on promoter driven GFP expression levels. It was 
hoped that positive control values, displaying no effect on OD or F, would be 
presented in the top right quarter and negative controls, affecting OD and F would be 
observed in the bottom left corner.  
Figure 5.1 shows a high level of variance in F, indicating that a number of 
compounds may affect either cell density or mtrA expression. In order to select only 
those with an effect on mtrA expression, ten outliers from the group of points were 
manually selected for re-testing. These are displayed by a circle on the graph and 
named in table 5.1.  
There is a large group of compounds centred on the median mark for both F and 
OD. They display a lower level of both F and OD than the positive control values in 
the top right. 
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Figure 5.1 Spectrum Screen against mtrA expression. 
The optical density and fluorescence readings are displayed 
for each compound in the Spectrum library. The median 
values have been used as axis point to divide the graph into 
possible inhibitors of mtrA expression which do not affect cell 
density, top left, and inhibitors of cell growth, bottom left. Data 
points which were separate from the main group were 
selected (circled) and re-tested. These are names in table 5.1 
Fluorescence (F) 
Optical Density (OD580) 
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Because the mtrA gene target is fairly specific, we assume that not all of these 
compounds are affecting the TCS. It is more likely that they affect cell growth in 
some other way giving a lower reading of F.  The values circled stand out from the 
main group in that they do not display a lower OD than the positive control values, 
but display a lower F and are not part of the large group of compounds in the median 
range. The names, formulae and sources of these compounds are displayed in table 
5.1, none of which are known to be signal transduction inhibitors.   
NAME Formula Bioactivity Source F OD580 
STIGMASTEROL C29H48O  soya and calabar 
beans;  
186735 0.521 
CITICOLINE C14H26N4O 
11P2 
cognition 
enhancer,  
cytidine-5'-
diphosphocholine 
214927 0.547 
CARNOSIC ACID C20H28O4  Salvia spp, 
Rosmarinus 
officinalis 
219330 0.472 
TETRAHYDRO 
GAMBOGIC ACID 
C38H48O8  derivative 226869 0.506 
PRISTIMEROL C30H42O4  derivative of 
pristimerin 
230552 0.485 
7-OXO 
CHOLESTERYL 
ACETATE 
C29H46O3  Cliona copiosa 232658 0.469 
RHODOMYRTOXIN 
B 
C24H28O7  Rhodomyrtus 
macrocarpa 
234508 0.479 
AUSTRICINE C15H18O4 Anti 
inflammatory 
Compositae 235476 0.505 
BAICALEIN C15H10O5 antiviral 
(HIV) 
Scutellaria 
baicalensis 
236264 0.539 
METHOPRENE (S) C19H34O3 Ecto 
parasiticide 
synthetic 236431 0.486 
POSITIVE CONTROL    339962 0.528 
NEGATIVE CONTROL    214974 0.064 
Table 5.1: Spectrum Library Candidates. Names and descriptions of compounds 
considered for re-testing from Spectrum collection with their F and OD values from the initial 
screen. 
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5.2.1.2 LOPAC Library against mtrA expression  
Using the established assay, we then screened the LOPAC library. Fortunately, this 
library contained an intrinsic positive control that we were not previously aware of. 
Oleic acid, which was briefly discussed as a TCS inhibitor in the introduction, was 
identified as a hit in the LOPAC screen, confirming our assay. Figure 5.2 displays the 
OD and F readings for each well in this screen with oleic acid labelled in a different 
colour to show where hits of this screen should sit. As with the previous figure, the 
median values are shown as the axis lines to divide the graph into four quarters. The 
“hits” observed are displayed in table 5.2. Unfortunately in this assay, the variance in 
the negative controls was far more pronounced. Positive control wells displayed a 
huge range of variance in OD. However a trend can be seen from the top right 
quarter to the bottom left, in terms of the positive control readings, so the hits were 
selected according to their position away from this diagonal line. 
The basis for choosing hits from this screen was their position in relation to the oleic 
acid, which is known to inhibit the phosphorylation step of HK dimerization. Ten 
compounds, named in table 5.2, were selected and re-tested in triplicate. 
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Figure 5.2: LOPAC Screen against mtrA 
expression. . Fluorescence and optical density are 
shown for each compound screened, using the 
median value as the axis. Oleic acid, a known TCS 
inhibitor is labelled in light blue. Ten other 
compounds, shown in a circle, were selected for re 
testing. Their names, a brief description as well as 
their values for F and OD are shown in table 5.2 
Fluorescence (F) 
Optical Density (OD) 
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Positive Control              296366  0.290 
Negative Control              171356  0.053 
Table 5.2 LOPAC Library Candidates. Names and descriptions of compounds considered 
for re-testing from LOPAC collection with their F and OD values from the initial screen. This 
information was obtained from Sigma. 
 
5.2.1.3 NIH Library against mtrA expression  
The NIH screen was the largest compound library tested in this study.  This library 
has mostly been used to test potential anti-neoplastic agents and can be obtained 
from the NIH. It includes a large number of unknown compounds as well as a 
number of natural products. Figure 5.3 displays the F and OD of each compound 
tested with median values used as the X and Y axis in each case. Positive control 
values are mostly isolated to the top right hand corner, while antibiotic control values 
are in the bottom left. Hits from the top left hand corner were selected for re-testing.  
NAME Class Description F OD 
PROTRIPTYLINE 
HYDROCHLORIDE 
Adrenoceptor Norepinephrine reuptake 
blocker 
243046 0.441 
ODQ Cyclic Nucleotides Potent and selective NO-
sensitive guanylyl cyclase 
inhibitor 
246851 0.464 
N - ACETYLPROCAINAMIDE 
HYDROCHLORIDE 
Na+ Channel Blocks Na+ channels and 
appears to have Class III anti-
arrhythmic activity; 
metabolite of Procainamide 
247850 0.416 
PARGYLINE 
HYDROCHLORIDE 
Neurotransmission MAO inhibitor, relatively 
selective for MAO-B 
249006 0.687 
NILUTAMIDE Hormone Antiandrogen 255868 0.569 
OLEIC ACID Phosphorylation Activates protein kinase C in 
hepatocytes; uncouples 
oxidative phosphorylation 
260912 0.656 
XANTHINE AMINE 
CONGENER 
Adenosine A1 Adenosine receptor 
antagonist 
263300 0.610 
L-ARGININE Nitric Oxide Nitric oxide precursor 266069 0.590 
OXOTREMORINE 
METHIODIDE 
Cholinergic Nonselective muscarinic 
acetylcholine receptor agonist 
266106 0.52 
S- (P-AZIDOPHENACYL) 
GLUTATHIONE 
Multi-Drug 
Resistance 
Glyoxalase and glutathione S-
transferase inhibitor 
269002 0.583 
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Table 5.3 shows the names (if known), formula, molecular weight and F and OD 
values of those compounds labelled “hits” for this screen. This information was 
obtained from the Developmental Therapeutics Programme (DTP) website which 
can be found at http://www.dtp.nci.nih.gov/docs/dtp_search.html.  
Most of the compounds labelled as hits for this screen have not been named, with 
the exception of Antineoplastic-92893 and Buclizine Hydrochloride, as shown in 
table 5.3. Consequently, there was little information available about these 
compounds other than their structure and formula. 
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Figure 5.3: NIH Collection Screen against mtrA expression. 
The median values of F and OD are shown where the X and Y 
axis cross to divide the screen into four quarters; potential TCS 
inhibitors in the top left, potential growth inhibitors in the bottom 
left, ineffective compounds on the right hand side. A large 
number of compounds seemed to decrease the mtrA induced 
expression of GFP, compared with the positive controls shown in 
green. Those circled were selected and tested in triplicate.  
Fluorescence (F) 
Optical Density (OD580) 
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Name NIH code Formula Molecular 
Weight 
F OD   
 NSC 73646 C6H16N4.H2O4S 242.0 210551 0.361   
 NSC 96606 C12H14N2O2 218.0 234878 0.261   
 NSC 63786 C10H10N4S 218.0 244330 0.216   
 NSC 3535 C13H19NO2S 253.0 215539 0.383   
 NSC 
133896 
C13H6N2O5 270.0 227222 0.520   
 NSC 
130915 
C12H21N3.2ClH  280.0 219812 0.413   
Antineoplastic- 
92893  
NSC 92893 C13H14AsNO3 307.0 217123 0.403   
 NSC 
166638 
C10H7Cl2F3N4O2 343.0 228152 0.437   
 NSC 97845 C22H27NO3 353.0 231052 0.546   
 NSC 
357777 
C19H15N5O.ClH 366.0 233207 0.495   
 NSC 18877 C20H10N2O4S2 406.0 227708 0.476   
Buclizine 
Hydrochloride  
NSC 25141 C28H33ClN2.2ClH 506.0 225434 0.445   
 NSC 
115448 
C44H20N2O8 705.0 227322 0.449   
 NSC 
382796 
C31H25N3O7 552.0 230822 0.464   
Positive control 
(average) 
   247467 0.385   
Negative 
control 
(average) 
   217468 0.056   
Table 5.3: NIH Library Candidates. Names and descriptions of compounds considered for 
re-testing with their F and OD values from the initial screen.  
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5.2.1.4 NIWA collection against mtrA expression  
A collection of marine extracts was also tested against the mtrA promoter. This 
collection contained a smaller number of samples than any other library and 
displayed no decrease in F while maintaining the OD of the culture compared with 
positive controls, as displayed in figure 5.4. The antibiotic controls indicate that a 
number of extracts had an effect on the growth of cells. All the other libraries used a 
constant concentration of 20 µM for all compounds but the NIWA collection was 
composed of crude marine extracts, so the final concentration of active compounds 
is unknown.  
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Figure 5.4: NIWA Collection Screen against 
mtrA expression.  Some extracts displayed 
growth inhibition with F and OD values close to 
that of the antibiotic controls. No extract seemed 
to affect F independent of cell density, since 
none show an F value much lower than positive 
controls, labelled in red.  
Fluorescence (F) 
Optical Density (OD580) 
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5.2.2 Drug screens with pSHigh_phoA 
The phoA promoter-driven F of GFP is relatively lower than that of MtrA. This 
presented a problem, as the variance in F between wells was very high. For library 
screens with phoA, an additional negative control was used to indicate F of the 
promoterless pSHigh plasmid construct in the same EDTA supplemented media. An 
un-induced phoA control was not really practical in this screen, since these cells 
would grow at a different rate to the cells grown in EDTA supplemented media. 
There were no significant results seen in this screen, as changes in intensity 
between positive and negative controls could not be discerned.  
5.2.2.1 LOPAC library screen with phoA 
Figure 5.5 shows the phoA activation and OD against the LOPAC library. Although 
the position of the oleic acid control is in the top left quarter, as expected, a large 
number of compounds seem to cause a decrease in F to levels lower than the 
promoterless control. This could indicate that the use of EDTA imposes conditions 
which make the cells more susceptible to compounds that would not necessarily give 
the same result in rich media. This construct was also used to screen against the 
NIWA collection with a similar result (this data is not shown).  
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Figure 5.5: LOPAC Screen against phoA expression. 
The F and OD values of this screen are displayed, with 
median values marking X and Y axis crossing points. The 
positive controls displayed a higher level of fluorescence 
than the promoterless construct, however most values from 
the LOPAC data was also lower than the negative pSHigh 
control. Phosphorylation inhibitor oleic acid, shown in light 
blue is surrounded by a large number of compounds rather 
than as an outlier. 
Fluorescence (F) 
Optical Density (OD580) 
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5.2.2.2 Comparison of mtrA and phoA LOPAC screens: 
Even though the phoA screen was not successful in showing any hits, the oleic acid 
control was where we expected it to be; the top left hand quarter of the graph. In 
order to determine whether any of the proposed hits from the mtrA LOPAC screen 
fell in this quadrant during the phoA screen they have been represented on the same 
graph as the previous figure 5.5 in a different colour. If any of the compounds 
highlighted in the mtrA screen were not specific to the MtrB/ MtrA TCS and could 
inhibit different TCS as well, they might show up in the top left hand corner of the 
phoA screen as well. Figure 5.6 shows the same data as figure 5.5, with the hits 
from the mtrA screen highlighted in red and oleic acid in black and labelled.  
  
 
 
Figure 5.6 phoA and mtrA 
LOPAC screen 
Figure 5.6: Identification of mtrA hits on LOPAC Screen against phoA. The F and OD 
values of this screen are displayed, with median values marking X and Y axis crossing points. 
Compounds which gave a lower F reading in the mtrA screen are shown in red. A few values 
lie in the bottom left hand corner, indicating they may inhibit growth under the conditions of this 
screen, however none lie far to the left of the top corner which would signify that they are non-
specific TCS inhibitors. 
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Only one of the compounds from the LOPAC screens showed inhibition of both mtrA 
and phoA driven promoter expression. This indicated that any of the other potential 
inhibitors identified during the mtrA screen were specific to this one out of the two 
signal relay system tested. It is also likely that this method of extrapolating hits may 
inadvertently overlook compounds with TCS inhibitory properties because only a 
small number of points were selected from each graph. Another factor is that 
compounds which conferred a low F reading, as well as a low OD580 reading are left 
out, as it was assumed these compounds are cytotoxic.  
5.2.3 Validation of hits from library screens in triplicate 
In order to verify that the compounds identified as hits from the library screens 
inhibited mtrA activation, selected compounds from each screen (named in tables 
5.1 – 5.4) were re-tested in triplicate. For this validation assay the positive control 
promoter hsp60 and the promoterless pSHigh plasmids were included. The positive 
control would show whether the effect of the compound was a result of a global 
decrease of gene expression in the cell, or via an MtrA specific mechanism. Only 
one of the compounds tested in triplicate, oleic acid, displayed a reproducible effect 
on mtrA expression. They also displayed no change with respect to hsp60 
expression, indicating that hits selected from each screen had been false positive 
results and not inhibitors of gene expression.     
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5.2.4 Validation of whole cell based screen with oleic acid and palmitoleic acid 
dilution series 
None of the compounds picked up as hits in the library screens gave a significant 
decrease in mtrA expression during a validation screen, where each compound was 
tested in triplicate. In order to show that this screen could potentially identify TCSi, 
had any been present in the libraries tested, a series of oleic acid and palmitoleic 
acid concentrations were tested for modulation of mtrA activation. Figures 5.7 and 
5.8 show the mtrA expression in the presence of palmitoleic and oleic respectively at 
three different concentrations of the fatty acids. These graphs show that the mtrA 
promoter driven GFP expression decreases with the concentration of both oleic and 
palmitoleic acid added, while the effect on the hsp60 promoter expression is 
unchanged. 
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Figure 5.7: Oleic Acid dilution series against mtrA expression. A) MtrA and B) hsp60 
expression under the influence of the oleic acid. The effect of final concentrations of 50, 25 
and 12.5 µM of oleic acid on the expression of mtrA is dose dependent as the F of the 
reporter decreases with concentration, while hsp60 expression does not change with 
concentration. Error bars indicate the standard deviation between triplicate cultures.  
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Figure 5.8: Palmitoleic Acid dilution series against mtrA expression. A) MtrA and B) 
hsp60 induction under the influence of the palmitoleic acid. The effect of final concentrations 
of 50, 25 and 12.5 µM of palmitoleic acid on the expression of mtrA is dose dependent as 
the F of the reporter decreases with concentration, while hsp60 expression does not change 
with concentration. A solvent control of ethanol is shown as 0 µM palmitoleic acid. Error bars 
indicate the standard deviation between triplicate cultures.   
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5.3  Discussion 
 
5.3.1 Compound Library screens and TCS controlled gene expression 
5.3.1.1 Spectrum Collection 
A total of 2000 compounds from the Spectrum library were tested for activity against 
the expression of the mtrA promoter. Figure 5.1 shows that compounds had an array 
of effects on both OD and F.  The positive controls of M.smegmatis containing 
pSHigh_mtrA remain in the top right hand corner of the graph, indicating no 
reduction in F or OD, while antibiotic controls shown in the bottom left corner indicate 
background F and turbidity produced by media without cells. The compounds have a 
range of effects with a main cluster halfway between these controls. The general 
trend shows that a number of compounds effect the growth of cells to some extent. 
The cluster of data points that is lower than the positive controls indicates that the 
presence of most compounds has some affect on cells either acting on the promoter 
activity or outright cell growth. Compounds that inhibit cell growth are present near 
the antibiotic control points. This graph depicts a number of hits which have a low 
level of F and no change in OD compared with positive controls.  
5.3.1.2 NIH Collection 
The NIH collection is a free library of compounds available from NCBI. 2240 
compounds were tested from this library including a number from the natural 
diversity set. Unlike the Spectrum screen the positive controls are not all located in 
the top right hand quarter of the graph; however there is a clear trend between 
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positive and negative controls. A total of 15 hits were selected for validation from this 
screen.  
5.3.1.3 NIWA samples 
A selection of marine samples donated by the National Institute of Water and 
Atmospheric Research (NIWA) in Wellington were also tested in this manner. This 
screen contained 290 samples, none of which gave an F reading lower than the 
positive controls. It did produce a number of data points with F and OD inhibition 
which will be used to verify future work with this library in a search for anti-
mycobacterial drugs.  
5.3.1.4 LOPAC library 
The LOPAC collection, Library of Pharmacologically Active Compounds, available 
from Sigma Aldrich includes 1280 compounds. This screen was carried out for both 
mtrA and phoA driven GFP expression. Ten compounds were selected and retested 
with the mtrA construct. A major benefit of this library screen was the presence of a 
phosphorylation inhibitor oleic acid, displayed separately on figures 5.5 and 5.6. This 
compound was identified as a hit for the mtrA screen, conveniently providing an 
intrinsic control to our assay. The phoA screen shows oleic acid in the top left quarter 
of the graph but not as a hit as in the mtrA screen. 
The phoA screen was less successful in that the difference between EDTA induced 
pSHigh_phoA and promoterless pSHigh was not well defined. A majority of the data 
points fell below this negative control, indicating there was some other interaction 
occurring between compounds and GFP expression.  
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 Interestingly none of the mtrA hits identified were common to inhibitors on the phoA 
screen, indicating the library search had not successfully unearthed a non-specific 
inhibitor of HK to RR phosphotransfer. A recent study has highlighted the 
relationship between drug efficacy and the conditions in which cells are grown 142. It 
has already been established that an anti-TB drug metronidazole is much more 
effective in hypoxic conditions 159. These considerations add a level of complexity to 
drug screening as most in vitro drug screening is carried out in a specific media, and 
results can vary if these parameters are changed. 
5.3.2 Discussion on the Screen 
There a number of noteworthy limitations to this screen.  Firstly the variance 
observed between samples when dealing with a multitude of compounds in this 
manner. The presence of outliers in both directions of the graph indicate that there is 
a significant chance of error that can come from a number of sources, from human 
handling and data processing error to technological errors such as pinning of 
compounds or reading of wells, the latter obviously far less likely. False positive 
“hits” may arise from a number of scenarios 
 Contamination of a well in the assay which was not picked up upon 
inspection of plate, giving a high OD but no F 
 If the compound has an effect on the GFP protein processing at any point 
a misfolded protein may not give off the same F as positive controls 
 Coloured compounds can alter the OD reading of its well; a highly 
coloured compound may give a reading which indicates high cell viability 
when the chemical has in fact inhibited growth  
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This data shows that the best results from the HTP screen did not translate to a 
decrease in F when repeated in triplicate. The high level of variance displayed in 
control and compound containing wells suggests that there is a loss of uniformity 
when working in a 96 wp set up in terms of OD and F. The validation results call into 
question the methods used during the HTP screen, and whether adequate 
parameters had been set. Given the high level of variance seen in a HTP screen with 
such a large number of compounds, the hits listed may either be false positives from 
the initial screens or too variable in the validation to be observed. 
One concern with using the mtrA promoter in these screens stems from the fact that 
mtrA may be essential in M. tuberculosis. It has not been previously described as an 
essential gene in M. smegmatis; however it brings to light the concept that an 
inhibitor of this system may display an effect on cell growth if it is indeed essential. 
However, the data from both LOPAC screens and the oleic and palmitoleic acid 
experiments indicate that at a low concentration this inhibitor does not affect the cell 
density.   
One way that this result may have been improved would have been to use another 
expression condition for mtrA; minimal media with EDTA. The decision to use rich 
media over minimal media stemmed from an observation that cells grew with much 
more uniformity in the former. As observed with the phoA promoter screens, minimal 
media gives a lower dynamic range making the difference between induced and 
uninduced GFP expression less pronounced.  
 
 
Figure 6.1 Validation assay: MtrA  
Figure 6.2 Validation assay: MtrA  
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5.3.3 Validation of the screen with cis fatty acids 
Figures 5.7 and 5.8 show a dose dependent decrease in F in the presence of oleic 
and palmitoleic acid. This trend is not seen in F which is restricted to the mtrA and 
not the hsp60 promoter indicating that their mode of action is not on the GFP 
reporter itself or general global gene expression. 
Oleic and palmitoleic acids are thought to inhibit phosphorylation of ATP to ADP in 
the histidine kinase activation 160. They occur naturally in human, animal and plant 
fat and do not inhibit bacterial growth 130. This activity was discovered in a kinase 
involved in sporulation named KinA of B. subtilis. The mode of action of cis 
unsaturated fatty acids is not known, except that they inhibit KinA –ATP binding in a 
non competitive fashion with an IC50 of around 20 µM 
160. Oleic acid is a component 
of mycobacterial media OADC, and must be broken down by the bacteria as an 
energy source, so its inhibitory activity may only act at a certain concentration, or in a 
particular arrangement of the fatty acid.  
Oleic acid has also been described as an uncoupler of mitochondrial oxidative 
phosphorylation and an activator of protein kinase C 161, 162. The full extent of its 
activity on phosphorylation reactions in mycobacteria is unknown.   
This data shows in principal that using a serial dilution setup with three strains 
containing pSHigh_MtrA, pSHigh_hsp60 and pSHigh each in triplicate is a method 
which will illuminate TCSi from a library of compounds. The screen in this study 
aimed to test as many compounds as possible for activity; in other words, one 
compound per well at one concentration. This data clarifies the need for compounds 
to be tested in a dilution series and in triplicate. This method is more time consuming 
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and probably reduces the number of compounds which can be tested per screen, but 
clearly yields a more reproducible result. 
Previous work in HTS for active compounds has developed methods for statistical 
validation of primary screening 142, 163. This method determines the validity of hit 
selection in an assay based on a number of factors. In our assay only one hit was 
validated, indicating that this screen requires a significant amount of optimisation in 
order to obtain an acceptable hit rate or z score.         
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6.1 Summary of Findings 
The primary accomplishments of this thesis were the optimisation of a high copy 
number plasmid to report gene expression, the application of this methodology to 
TCS controlled genes and an analysis of the expression of these genes under 
stress. This led to a number of chemical library screens, in search of compounds 
which inhibit the TCS signal transduction. In theory, compounds could be potential 
TCS inhibitors if they exert a drop-off in TCS controlled gene expression compared 
with what is normally expected under particular conditions. Since they change the 
eventual outcome of the signalling mechanism i.e., the induction of a particular gene, 
these compounds could be affecting any part of the TCS signalling mechanism.  
The insertion of the oriM high mycobacterial origin of a replication and the gfpmut2 
gene resulted in the successful optimisation of a reporter plasmid. The results in 
Chapter Three demonstrate that the presence of the plasmid provides a high level of 
F under the influence of the hsp60 promoter without causing any obvious detrimental 
effects on M. smegmatis cells. This plasmid was further equipped with alternative 
promoters which were selected after a literature search of TCS controlled genes; 
namely hspX, phoA and mtrA. 
The activation of these genes was explored under a number of stress conditions 
including oxygen and nutrient starvation, antibiotic stress, heat shock, cold shock, 
SDS and ethanol. Out of all the stress conditions tested, the most noteworthy effect 
on the expression of hspX was seen during oxygen starvation.  
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PhoA activation was observed under phosphate starvation and magnesium 
starvation, by chelation with EDTA. The mtrA promoter gave high levels of 
expression in rich media as well as under the influence of EDTA. The effect on hspX 
during oxygen starvation and phoA during phosphate starvation was expected given 
their proposed function. The induction of both phoA and mtrA under the influence of 
magnesium starvation lead to a number of new questions about the influence of 
magnesium, or at least the chelator EDTA, in relation to the SenX3/ RegX3 and 
MtrB/ MtrA systems.  
A number of assumptions have been made about the conditions experienced by AFB 
within the macrophage and granuloma which cannot be truly replicated in vitro. It is 
known that mtrA is induced after macrophage infection in M. tuberculosis and this 
result brings to light the possibility that magnesium concentration or some other 
effect of the chelating agent on media may be involved in the MtrB sensor kinase 
activation.    
Chemical library screens were carried out using the mtrA reporter expression as an 
indicator of TCS inhibition, as this promoter produced high levels of F in rich media. 
A number of compounds decreased the expression of mtrA after the incubation 
period of the library screens. Re-testing of these compounds in triplicate did not 
confirm a considerable difference in expression. We did, however, unearth a known 
TCSi in the LOPAC library which was identified as a hit in this screen. Further 
experiments on this compound and palmitoleic acid, another cis fatty acid, indicated 
that the F induced by mtrA was reduced in a dose dependent manner in a serial 
dilution assay.  
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Importantly, the screen identified an intrinsic TCSi control, oleic acid, out of 
thousands of compounds tested. This compound has not previously been shown to 
inhibit any TCS in mycobacteria. 
6.2 Critique of the screen 
There are a number of benefits to this screen compared with isolated protein 
methods. In theory any inhibition of the signal transduction mechanism will be 
highlighted by this screen. The method can be carried out in a high through put 
manner to test thousands of compounds at a time in one assay.  
This method could be adapted to other targets. As well as finding inhibitors of 
transcriptional control, the use of GFP translational fusions can be applied to 
discover inhibitors of proteins which are controlled by other means.   
A significant point here is the ability to test for inhibitors of genes that may be 
essential. Few methods can directly target a gene which the organism cannot live 
without, but the reduction in mtrA promoter activation observed as a result of oleic 
acid showed that changes in gene expression can be observed in this way without 
completely inhibiting cell growth. One the other hand, this will depend on the MIC of 
the inhibitor in question and the concentration of compounds used in a screen. In all 
likelihood a successful candidate drug which inhibits TCS would also decrease the 
cell density of a population and thus be missed out in our screen.  
However, more potent inhibitors may not have been picked up by our methods. This 
situation could be remedied by a more relative measure of F, by recording 
information on a single cell basis with FACs. It comes down to a compromise 
between high throughput and relativity of gene expression. By using a whole cell 
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assay thousands more compounds can be screened than in a low throughput single 
cell counting method such as FACS. 
The use of a reporter of gene expression, however accurate, is essentially an 
indirect method of testing two component signal transduction. We do not know how 
many other regulators are acting on the genes in this study. Previous work has 
shown that all of the selected genes contained RR binding sites within their 
promoters, but this does not exclude the possibility of other factors such as universal 
sigma factors 100, 108, 150. The mechanisms controlling gene expression are, in all 
likelihood, much more complicated than simply one response regulator acting as a 
transcription factor on a gene. There are probably multiple levels of regulation for 
every gene in an organism’s genome. The constitutively expressed control promoter 
is one way of showing if a condition or inhibitor is affecting the expression of a 
specific gene; however in practice the control of these important housekeeping 
genes could be controlled another way.  
Although the TCSi oleic acid was picked up this screen a number of other false 
positive results were also picked up using this method. Clearly the level of variance 
in terms of both F and OD observed from screens of this size can lead to false 
positive results and perhaps screens of this nature should be repeated before 
selecting hits to re-test. In order to test as many compounds as possible each library 
was only screened once. This meant that there was no way to test the statistical 
significance of “hits”. In hindsight, this meant that the screen was not an efficient way 
of finding TCS inhibitors. If each library had been tested in triplicate it is likely that the 
rate of false positives would have been reduced. Hit selection is an area which 
requires significant development in order to obtain an acceptable z score. Our 
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method for manually selecting compounds based on their position on the scatter plot 
did not render an acceptable hit rate as described in other work on HTS analysis 163.  
Inevitably, the number of compounds being screened will affect the degree of 
accuracy each screen will present, since larger screens give more variable results. 
Perhaps the parameters of “hit” selection could be optimised.  
One aspect of the screen, which was briefly mentioned earlier, is the relativity of 
results in terms of the number of plasmids per cell. As with all plasmid reporter 
methods, including xylE expression, one must assume that this remains relatively 
constant between strains and conditions. It is generally accepted that using 
appropriate controls will balance out any changes in copy number from cell to cell. It 
is worth noting here that oriM high increased copy number from 5 to anything 
between 32 and 64 copies per cell raises questions about this assumption of 
consistency. Large differences in copy number of the plasmid from cell to cell may 
be the cause of the variance seen in these screens. The benefits of this new origin of 
replication are convincing (Chapter One), but the resulting variance is something that 
needs to be considered.  
In this study, over 4500 compounds from a number of sources were screened, a fair 
few less than the 25,000 compounds tested to discover the first TCS inhibitors 127. A 
possible future direction in this area could be the study of fewer compounds after a 
more rational method of compound selection. For example, selecting compounds or 
classes of compounds identified using an in silico screening approach based on the 
protein structure of the target. The current work highlighted the potential of cis fatty 
acids, so perhaps this is a class of compounds worth developing.  
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6.3 Future Direction 
The identification of oleic acid in the LOPAC assay and the dose dependent 
inhibition displayed by oleic and palmitoleic acids indicate that this methodology 
could be applied to study more compound libraries against the reporter system. 
Before further libraries are tested, there is a substantial amount of optimisation 
required in terms of HTS. A number of statistical tests, for example, would help to 
indicate an improved hit rate as a result of a more refined selection criteria. As well 
as increasing the number of chemicals tested, there is also the possibility that new 
TCS controlled genes could be screened in this manner. Other M. smegmatis, M. 
bovis BCG or avirulent M. tuberculosis TCS controlled genes could be investigated 
using this method of screening.  
The observation that cis fatty acids may inhibit the expression of both mtrA and phoA 
is an important finding, as this inhibition has so far only been observed in the Bacillus 
subtilis KinA protein. The method of action has not yet been elucidated, except that 
fatty acids act in a non competitive manner with respect to ATP during 
phosphorylation. It would be interesting to solve the crystal structure of MtrB and 
compare it with that of KinA for homologous sites. 
The large number of compounds screened was achieved in this study using a fast 
growing species of mycobacteria. Slow growers would require lengthy assays, but 
could also potentially be screened either with entire libraries or a selection of hits 
discovered by assays with fast growers. 
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Another application of these methods is the study of genes induced within the 
macrophage. In particular, mtrA expression, which has been previously shown 
during macrophage expression, could induce GFP at a much higher level during 
intra-macrophage growth. If the difference between induced and un-induced GFP is 
more apparent, the level of variance seen in these screens could be reduced. 
As well as TCS, other signalling such as Serine Threonine Protein Kinases  and one-
component regulators could be selected and screened for in this manner. 
DevS/DevR and other dormancy related targets would be highly appropriate targets 
to develop in this sort of screen.  
PhoP/ PhoR could also be targeted in this manner by analysing the expression of the    
gene under its control. The benefits of inhibiting this system would be plentiful, as it 
is so important to the survival and virulence of M. tuberculosis. Its significant role in 
cell wall maintenance would make any inhibitor capable of knocking out this 
signalling mechanism an excellent drug candidate. Even if it did not inhibit growth 
outright, its use in combination with other drugs such as cell wall targets could 
significantly reduce the treatment time required for TB. 
Other parts of this thesis underline the need for further studies into the conditions of 
expression of TCS controlled genes. In particular mtrA; how and why this gene is 
expressed and its protein product’s function within the cell are all important 
questions, due to its significance as an M. tuberculosis essential gene. This work has 
revealed a possible condition of its expression to be magnesium starvation. Further 
work to validate this may help to understand its function and potential as a drug 
target.  
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There are generally two ways to go about discovering drug targets for a particular 
pathogen. We argue that a targeted approach to significant genes involved in 
latency, dormancy and survival within a macrophage cell may be a better way to 
prevent TB than exploring any and all compounds which affect the growth rate of the 
species. For a number of reasons, M. tuberculosis requires a different approach to 
drug discovery, compared with rapidly growing pathogens. The high incidence of 
drug resistance, its extended incubation and latency period and its apparent switch 
to a reductive metabolism make M. tuberculosis a difficult pathogen to eradicate. 
Screening for compounds, and selecting “essential” targets by measuring simply how 
they affect the level of growth of the organism in rich media is not the best 
representation of what the pathogens really cannot survive without in vivo. The mtrA 
gene has been labelled essential, however, its role in macrophage infection has also 
been established, making it the sort of target which should be explored further.  
Similarly, expression of the hspX reporter plasmid represents the switch to a 
reductive metabolism, something which makes the pathogen extremely successful. 
As a drug target, or an indicator of the cell dormancy program, this gene is highly 
useful in the study of latency. Compounds which affect this and other dormancy 
related targets could be worthy candidates in the effort to stop TB. 
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APPENDICES 
Appendix 1: PCR reactions 
The PCR reactions carried out in this study have been displayed below in A.1. 
Generally PCRs were carried in out using one of the three protocols depending on 
the desired fragment length and fidelity of PCR required. High Fidelity polymerase 
was used to clone promoters, gfpmut2 and oriM high. In the case of screening for 
fragment insertion into a plasmid, a regular polymerase was used such as Mastermix 
(Bioline). Modifications to annealing temperatures were made depending on 
particular primer melting temperatures in some cases. 
A.1 PCR reactions in this study 
a) High Fidelity PCR: Standard protocol for amplifying promoters and gfpmut2 
Temperature Time Cycles 
94oC 10 minutes  
94oC 1 minute  
30 56oC 1 minute 
68oC 1 minute 
12oC hold  
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b) High Fidelity PCR: Gradient protocol for amplifying long fragment oriM high 
Temperature Time Cycles 
94oC 10 minutes  
94oC 1 minute  
30 55 -65oC 1 minute 
68oC 1 minute  
68oC 10 seconds  
12oC hold  
  
 
c) Standard PCR: Screening fragment insertion using pTKmx_F1 primer 
Temperature Time Cycles 
94oC 10 minutes  
94oC 1 minute  
30 44oC 1 minute 
72oC 1 minute 
72oC 10 seconds  
12oC hold  
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Appendix 2: Ligation Reactions 
A number of ligation reactions were carried out in this screen. The method used was 
altered depending on whether the reaction involved one or two restriction enzyme 
sites. Since the pSHigh plasmid had only one cloning site infront of gfpmut2 the 
plasmid was first incubated with CIP to reduce the amount of self ligation occurring in 
the reaction. Consequently a larger volume of plasmid was added to these reactions 
as the concentration was reduced by the DNA clean up step after CIP incubation. 
The volume of fragment added was also increase to give a more efficient reaction by 
increase the fragment to plasmid ratio. In addition the efficiency off each reaction 
was observed by carrying out a negative control with distilled water, as the number 
of colonies on the negative control plate were indicative of self ligation of the 
plasmid. The following tables (A.2 a, b and c) describe the stock concentrations and 
volumes of reagents used in this study for cloning into a) cloning vectors, b) pOT71 
and c) pSHigh.  
 
 
 
 
 
 
 
 
Appendices 
 
152 
 
A.2 Ligation Reactions used in this study 
 Stock Concentration In a 10 µL reaction 
Promoter fragment variable 7 µL 
TA cloning vector 1 ng 1 µL 
T4 ligase 0.4U/ µL 1 µL 
T4 ligase buffer 10 x 1 µL 
a) Ligation reaction for cloning vectors 
 Stock 
Concentration 
In a 10 µL 
reaction 
Promoter fragment or SDW variable 7 µL 
Reporter plasmid pOT71 (after digestion 
with EcoRI and BamHI) 
variable 1 µL 
T4 ligase 0.4U/ µL 1 µL 
T4 ligase buffer 10 x 1 µL 
KpnI 1U/µL 1µL 
b) Ligation reaction for pOT71 
 Stock 
Concentration 
In a 10 µL 
reaction 
Promoter fragment or SDW variable 20- 30 µL 
Reporter plasmid pSHigh (after digestion 
with KpnI and incubation with CIP) 
variable 2 µL 
T4 ligase 0.4U/ µL 2 µL 
T4 ligase buffer 10 x 2 µL 
c) Ligation reaction for pSHigh 
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Appendix 3: Restriction Enzyme Digestion 
Restriction enzyme reactions were carried out according to the manufacturer’s 
instruction using appropriate buffers for each reaction. This information available 
from NEB. Checking for insertion of fragment to cloning vector required only a single 
enzyme digest desctibed in table A.3 a). Other digestion reactions involving the 
removal of fragments, or cutting of a plasmid before fragment insertion were carried 
out with a longer incubation period and appropriate enzymes. Restriction enzyme 
digestion reactions to remove the fragment from the cloning vector or pre ligation 
cutting of reporter plasmids are displayed in tables A.2 b) for pOT71 and c) for 
pSHigh. The reaction volume was altered in some cases to increase the final volume 
of cut DNA.  
A.3 Restriction Enzyme Digestion 
 Stock Concentration In a 10 µL reaction 
Cloning Vector + insert Variable 8 µL 
EcoRI 1U/ µL 1 µL 
EcoRI buffer 10x 1 µL 
a) Digestion of cloning vectors to check for insert 
 Stock Concentration In a 10 µL reaction 
Cloning vector + insert/ pOT71 variable 7 µL 
EcoRI 1U/µL 1 µL 
BamHI 1U/µL 1µL 
NEB buffer 2 10 x 1µL 
b) Digestion of pOT71 plasmid before insertion of promoters 
 Stock Concentration In a 10 µL reaction 
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Cloning vector + insert/ pSHigh variable 7 µL 
KpnI 1U/µL 1 µL 
BSA 10 x 1µL 
NEB buffer 3 10 x 1µL 
c) Digestion of pSHigh plasmid before insertion of promoters 
 
 
Appendix 4: Preparation of Calcium Competent DH5α Cells 
Calcium competent Escherichia coli DH5α cells were prepared for use in cloning 
procedures by the following protocol, ensuring all solutions and cells were kept on 
ice during preparation. TFB I and II are solutions used to induce competency as 
described by Hanahan et al [172] and are made up with the following concentrations 
of metal salts, glycerol and sterile distilled water before sterile filtration with a 0.22µM 
Millipore filter: 
TFB I:   for 100mL  final concentration 
MnCl2   0.629g    50mM 
CaCl2   0.147    10mM 
K acetate  0.294    30mM 
Glycerol  15mL    15% 
SDW    85mL 
 
TFB II   for 100mL  final concentration 
Na MOPS (pH7) 0.209    10mM 
CaCl2   0.629    75mM 
KCl   0.075    10mM 
Glycerol  15mL    15% 
Appendices 
 
151 
 
 
DH5α cells from a freezer stock were incubated with agitation at 37oC overnight in 
3ml liquid cultures of LB with 10mM MgCl2 with a negative media control to ensure 
there was no contamination. Cells were then inoculated into four 50mL cultures of 
the LB with 10mM MgCl2 in 250mL flasks and grown for around two hours until their 
OD600 was between 0.4 and 1.0. Cells were then transferred to 50mL flacon tubes 
and stored on ice to inhibit further growth. Cell suspensions were then spun down in 
a refrigerated centrifuge at 4 oC for 10 minutes at 5000rpm and resuspended in 40 
mLs of competence inducing TFB I solution before further incubation on ice for two 
hours. Each culture was then spun down again at 4 oC for 10 minutes at 5000rpm 
and resuspended in 4mLs of TFB II solution and kept on ice. Cells suspended in TFB 
II were transferred to eppendorf tubes and snap frozen then stored at -80 oC until 
required for transformation.  
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Appendix 5: Preparation of Electrocompetent Mycobacterium smegmatis 
mc2155 
Electrocompetent cells were prepared by a method revised from Sambrook and 
Russel  Volume 1, 1.12-1.14 [157] . 
Mycobacterium smegmatis mc2155 cells from an LA plate were incubated with 
agitation at 37 oC overnight in 10ml liquid cultures of LB with a negative media 
control to ensure there was no contamination. 2 – 3 mLs of this cells culture was 
inoculated into 100mLs of LB and grown for around five hours until their OD600 was 
between 0.5 and 1.0. Cells were then transferred to two 50 mL falcon tubes and 
stored on ice to inhibit further growth for 20 minutes. Cell suspensions were then 
spun down in a refrigerated centrifuge at 4 oC for 10 minutes at 5000 rpm and re-
suspended in 50 mL 10% cold glycerol. This incubation and pellet step was repeated 
three times before cells were finally re-suspended in 2mLs of cold 10% glycerol 
before they were dispensed into eppendorf tubes and stored at -80oC until required 
for transformation. 
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Appendix 6: Media used in this study for DH5α cells 
DH5α cells used for cloning were grown on solid media Luria Agar (LA) or Luria 
Broth (LB) both from Sigma.  Overnight cultures of TA cloning vector containing cells 
were grown in LB supplemented with Ampicillin and Kanamycin when using pCR2.1 
or just Ampicillin for pLUG vector. For blue/white colony selection, using β-
galactosidase gene disruption, tranformed cells were grown on LA containg the 
same concentration of antibiotics as well as IPTG and Xgal. 
Solid Media (LA) 
 Kanamycin 50 µg/mL 
 Ampicillin 200 µg/mL 
 Xgal 40 µg/mL 
 IPTG 100 µg/mL 
Liquid Media (LB) 
 Kanamycin 50 µg/mL 
 Ampicillin 200 µg/mL 
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Appendix 7: Media used in this study for mc2 155 cells 
All plasmids used in this study contained the Kanamycin resistance cassette ophA. 
Accordingly, all experiments using mc2 155 were supplemented with Kanamycin on 
both solid and liquied media. In order to obtain planktonic growth of liquid cultures, 
media was also supplemented with D-arabinose and Tween80. All media was 
autoclaved for sterilisation before use. 
Solid Media (LA) 
 Kanamycin 50µg/mL 
Liquid Rich Media (LB) 
 Kanamycin 50µg/mL 
 D-arabinose 100µg/mL  
 0.1% Tween80 
Nutrient starvation experiments were carried out using Hartman deBonts minimal 
media made from a base of metal salts, Tween80 and SDW. Phosphate and Nitrate 
sources were added to this base from stock solutions names 100X P and N 
respectively, while glycerol was added as a Carbon source.  
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Metal Salts    (in 1L SDW) final concentration 
 CaCl2.2H20   0.10 g   1 mM  
 CoCl2.2H20   0.04 g   240 µM 
 CuSO4.5H20   0.02 g   80 µM 
 EDTA    1.00 g   3.4 mM 
 FeSO4.7H20   0.50 g   1.8 mM 
 MgCl2.6H20   10.00 g  50 mM 
 MnCl2.2H20   0.10 g   621 µM 
 NaMoO4.2H20   0.02 g   90 µM 
 ZnSO4.7H20   0.20 g   732 µM 
100 x Nitrogen 
 (NH4)2SO4   200 g   1.5 M 
100 x Phosphates 
 K2HPO4    155 g   1 M 
 NaH2PO4     85 g   700 mM 
 
 
HdeB base was made using 945 mL of SDW with 10mL metal salts and 5 
mLs 10% Tween80. For each sort of media, mimimal, Carbon starvation, Nitrogen 
starvation and Phosphate starvation, 960mL of HdeB base was used as well as 
nitrogen, carbon and phosphate sources as shown in the table below. For 
Appendices 
 
156 
 
nutrient starvation experiments, the 4 levels of starvation were investigated using 
a range from 0% -100% as highlighted. 
 HdeB 
Base 
(mL) 
100x 
Nitrogen 
(mL) 
100x 
Phosphates 
(mL) 
10% 
Glycerol 
(mL) 
SDW 
(mL) 
5M 
NaMOPs 
(mL) 
Minimal 
Media 
960 10 10 20 0  
Nitrogen 
Starvation 
960 0.1 - 10 10 20 9.9 – 0.1  
Phosphate 
starvation 
960 10 1 - 10 20  10 - 1 
Carbon 
Starvation 
960 10 10 8 - 20 12 - 0  
Table A.3 Alterations to HdeB media for nutrient starvation 
 
 
 
 
